Systems and methods for narrowing a wavelength emission of light

Information

  • Patent Grant
  • 9383263
  • Patent Number
    9,383,263
  • Date Filed
    Tuesday, December 17, 2013
    10 years ago
  • Date Issued
    Tuesday, July 5, 2016
    7 years ago
Abstract
The present invention generally relates to methods and systems for narrowing a wavelength emission of light. In certain aspects, methods of the invention involve transmitting light through a filter and passing a portion of the filtered light through a gain chip assembly at least two times before that portion of light passes again through the filter.
Description
FIELD OF THE INVENTION

The present invention generally relates to methods and systems for narrowing a wavelength emission of light.


BACKGROUND

Optical coherence tomography (OCT) is an established medical imaging technique that relies on light for producing an image. In OCT, light from a broadband light source is split by an optical fiber splitter with one fiber directing light to a sample path and the other fiber directing light to a reference path mirror. An end of the sample path is typically connected to a scanning device. The light reflected from the scanning device is recombined with the signal from the reference mirror to form interference fringes, which are transformed into a depth resolved image.


Numerous different OCT techniques have been developed, including swept source OCT. In swept source OCT, a narrowband light source is rapidly tuned over a broad optical bandwidth, and spectral components are encoded in time. Thus, image quality in swept source OCT relies on the swept laser source achieving very narrow bandwidths at very high frequencies (e.g., 20-200 kHz) over a very short period of time (e.g., 10,000-10,000,000 Sweeps/sec).


A typical set-up for a swept source OCT system uses a ring resonator that includes an optical amplifier, a tunable filter, and an optical coupler. Laser light at a specific bandwidth is produced by the optical amplifier and sent through the filter. The filter assists in maintaining the outputted light at the specific bandwidth. From the filter, the light travels to the optical coupler where a portion of the light is directed to an interferometer and the remainder of the light returns to the optical amplifier. The process repeats to achieve different bandwidths of light.


A problem with this set-up is that a single pass through an optical amplifier cannot impart enough energy to the light to obtain the very narrow bandwidths in an optimal amount of time. Another problem with this set-up is that a single pass through an optical amplifier cannot impart enough energy to the light to prevent broadening of the obtained bandwidth, particularly at higher frequencies. Both problems lead to degradation of image quality.


SUMMARY

The invention provides a ring resonator set-up for optical coherence tomography (OCT) in which light passes through an optical amplifier twice before it proceeds to an OCT interferometer. As encompassed by the invention, a first pass of light exiting the optical amplifier is directed back through the amplifier rather than continuing through the ring resonator. Light exiting the amplifier can be sent back through the amplifier by using, for example, a mirror. The light re-enters the amplifier, wherein it is amplified a second time. This re-amplified light is then transmitted through the ring resonator where it can continue onto the OCT interferometer. An optical coupler may be used to coordinate the passage of light between the amplifier and the rest of the ring resonator. The provided ring resonators may also include a filter for maintaining the narrow bandwidth of light after it has been amplified twice by the optical amplifier.


By passing the light through the amplifier twice during a single trip through the resonator, a narrowed bandwidth of light is achieved faster than only passing the light through an interferometer once before proceeding to the interferometer. The second pass through the amplifier in a single trip also imparts additional energy to the light, which prevents undesired broadening of the obtained bandwidth at higher frequencies. Accordingly, the provided ring resonators are able to produce high quality OCT images that avoid the image degradation problems associated with prior art ring resonator configurations.


The provided ring resonator can serve as a light source for a variety of applications, including medical imaging. For example, light leaving the ring resonator can be directed towards an OCT system. As noted above, the present invention is particularly suited for OCT due to the improvement of image quality.


In addition to the provided resonators, the invention also encompasses methods for narrowing a wavelength of light. The methods involve passing light through an optical amplifier of a ring resonator twice during one pass around the ring resonator. Using the provided methods, a narrow bandwidth of light is achieved in an optimal amount of time and image quality is improved.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 is a gain curve for a booster optical amplifier.



FIG. 2 is a diagram of a laser.



FIG. 3 schematically depicts a system of the invention, according to certain embodiments.



FIG. 4 is a schematic of an optical coherence tomography (OCT) system for use with systems and methods of the invention.



FIG. 5 is a schematic diagram of the imaging engine of an OCT system.



FIG. 6 is a diagram of a light path in an OCT system.



FIG. 7 shows the organization of a patient interface module in an OCT system.





DETAILED DESCRIPTION

The invention generally relates to methods and systems for producing narrow emissions of light. The invention can involve transmitting light through a filter and passing a portion of the filtered light through a gain chip assembly at least two times before that portion of the filtered light passes again through the filter. Broadband light is emitted from a light source and transmitted through a filter. The filtered light is passed through a gain chip assembly in which the light signal is amplified. The amplified light leaves the gain chip assembly, whereupon a portion of that light is sent back into the gain chip assembly, where it is amplified a second time. This re-amplified light is then directed back through the filter, wherein the whole process can repeat itself. Accordingly, the re-amplification of filtered light prior to its return to the filter can include sending the light through a gain medium in the gain chip assembly back through the gain chip assembly. This results in a second pass through the assembly gain medium before passing again through the filter.


Any optical filter is useful for practicing the invention. As encompassed by the invention, the filter receives light from a broadband light source and emits light of a predetermined wavelength. An optical filter typically has a peak reflectivity and a background reflectivity. The peak reflectivity indicates an amount of light output (reflected) at the specified wavelength, wherein a desired wavelength can be set in a tunable filter by placing mirrors in an etalon at an appropriate distance apart. The background reflectivity indicates an amount of light output at wavelengths other than the desired wavelength.


Typical filters might have, for example, a 20% peak reflectivity and a 0.02% background reflectivity. The ratio of these numbers (103) defines the filter contrast ratio, expressed in decibels (dB) (here, 30 dB). Thus, if light of a certain wavelength, for example, 1200 nm, is intended, the filter will transmit light at 1200 nm as well as a broad spectrum of light at lower power in a ratio of 30 dB.


In some embodiments, systems of the invention include an optical filter that can be tuned to a desired wavelength, i.e., a tunable filter. Amplified light of a selected wavelength is obtained by tuning the filter to that wavelength and sending the light into the gain medium with sufficient input power to achieve a desired output power.


Where an optical system requires a particular wavelength of amplified light, the light source may include an optical filter module such as a tunable optical filter in optical communication with a gain component.


In certain embodiments of the invention, the tunable filter is a voltage-controlled optical attenuator. In a VCOA, an optical attenuator is placed between an input and output lens for obstructing the path of an incoming light beam. The attenuator has variable attenuation (reflection, absorption, etc.) which is controlled for maintaining a preset power or wavelength of the outgoing light beam. To this end, a fraction of the outgoing signal is diverted to an output detector by reflecting off an end face of a lens, and processed for obtaining a control signal representative of the output power. An electric output displaces the attenuator to a position corresponding to a preset output power. Further detail on VCOAs can be found, for example, in U.S. Pat. No. 5,745,634, incorporated by reference herein in its entirety.


The invention also encompasses the use of a gain chip assembly that amplifies the power of light that is transmitted through it. As provided by the invention, light travels from the filter to the gain chip assembly for amplification. The gain chip assembly, or gain component, generally refers to any device known in the art capable of amplifying light such as an optical amplifier, laser, or any component employing a gain medium. A gain medium is a material that increases the power of light transmitted through the gain medium. Exemplary gain mediums include crystals (e.g., sapphire), doped crystals (e.g., yttrium aluminum garnet, yttrium orthovanadate), glasses such as silicate or phosphate glasses, gasses (e.g., mixtures of helium and neon, nitrogen, argon, or carbon monoxide), semiconductors (e.g., gallium arsenide, indium gallium arsenide), and liquids (e.g., rhodamine, fluorescein).


When light interacts with the material of the gain medium, several outcomes may be obtained. Light may be transmitted through the material unaffected or reflect off a surface of the material. Alternatively, an incident photon of light can exchange energy with an electron of an atom within the material by either absorption or stimulated emission. If the photon is absorbed, the electron transitions from an initial energy level to a higher energy level. In three-level system, there is a transient energy state associated with a third energy level.


When electron returns to ground state, a photon is emitted. When photons are emitted, there is a net increase in power of light within the gain medium. In stimulated emission, an electron emits energy ΔE through the creation of a photon of frequency v12 and coherent with the incident photon. Two photons are coherent if they have the same phase, frequency, polarization, and direction of travel. Equation 1 gives the relationship between energy change ΔE and frequency v12:

ΔE=hv12  (1)

where h is Plank's constant. Light produced this way can be temporally coherent, i.e., having a single location that exhibits clean sinusoidal oscillations over time.


An electron can also release a photon by spontaneous emission. Amplified spontaneous emission (ASA) in a gain medium produces spatially coherent light, e.g., having a fixed phase relationship across the profile of a light beam.


Emission prevails over absorption when light is transmitted through a material having more excited electrons than ground state electrons—a state known as a population inversion. A population inversion can be obtained by pumping in energy (e.g., current or light) from outside. Where emission prevails, the material exhibits a gain G defined by Equation 2:

G=10 Log10(Pout/Pin) dB  (2)

where Pout and Pin are the optical output and input power of the gain medium.


As encompassed by the invention, the gain chip component can be an optical amplifier or a laser. An optical amplifier is a device that amplifies an optical signal directly, without the need to first convert it to an electrical signal. An optical amplifier generally includes a gain medium (e.g., without an optical cavity), or one in which feedback from the cavity is suppressed. Exemplary optical amplifiers include doped fibers, bulk lasers, semiconductor optical amplifiers (SOAs) and Raman optical amplifiers. In doped fiber amplifiers and bulk lasers, stimulated emission in the amplifier's gain medium causes amplification of incoming light. In SOAs, electron-hole recombination occurs. In Raman amplifiers, Raman scattering of incoming light with phonons (i.e., excited state quasiparticles) in the lattice of the gain medium produces photons coherent with the incoming photons.


Doped fiber amplifiers (DFAs) are optical amplifiers that use a doped optical fiber as a gain medium to amplify an optical signal. In a DFA, the signal to be amplified and a pump laser are multiplexed into the doped fiber, and the signal is amplified through interation with the doping ions. The most common DFA is Erbium Doped Fiber Amplifier (EDFA), which features a silica fiber with an Erbium-ion doped core. An exemplary EDFA is the Cisco ONS 15501 EDFA from Cisco Systems, Inc. (San Jose, Calif.)


Semiconductor optical amplifiers (SOAs) are amplifiers that use a semiconductor to provide the gain medium. In a SOA, input light is transmitted through the gain medium and amplified output light is produced. An SOA includes n-cladding layer and p-cladding layer. The SOA also typically includes a group III-V compound semiconductor such as GaAs/AlGaAs, InP/InGas, InP/InGaAsP and InP/InAlGaAs, though any suitable semiconductor material may be used.


A typical semiconductor optical amplifier includes a double heterostructure material with n-type and p-type high band gap semiconductor layers around a low band gap semiconductor. The high band gap layers are sometimes referred to as p-cladding layers (which have more holes than electrons) and n-cladding layers (which have more electrons than holes). The carriers are injected into the gain medium where they recombine to produce photons by both spontaneous and stimulated emission. The cladding layers also function as waveguides to guide the propagation of the light signal. Semiconductor optical amplifiers are described in Dutta and Wang, Semiconductor Optical Amplifiers, World Scientific Publishing Co. Pte. Ltd., Hackensack, N.J. (2006) the contents of which are hereby incorporated by reference in their entirety.


Booster Optical Amplifiers (BOAs) are single-pass, traveling-wave amplifiers that only amplify one state of polarization generally used for applications where the input polarization of the light is known. Since a BOA is polarization sensitive, it can provide desirable gain, noise, bandwidth, and saturation power specification. In some embodiments, a BOA includes a semiconductor gain medium. The input and output of BOA can be coupled to one or more waveguides on an optical amplifier chip. FIG. 1 is a gain curve for a COTS booster optical amplifier.


Optical amplifier components can be provided in a standard 14-pin butterfly package with either single mode fiber (SMF) or polarization maintain fiber (PMF) pigtails, which can be terminated with any fixed connection (FC) connector such as an angled physical connection (FC/APC) connector. Optional polarization-maintaining isolators can be provided at the input, output, or both. In certain embodiments, the gain chip assembly includes a wavelength dependent reflector as a reflective surface of the optical amplifier, such as a mirror or one or more facets of the gain medium.


A laser generally is an optical amplifier in which the gain medium is positioned within an optical resonator (i.e., an optical cavity) as diagrammed in FIG. 2. In certain embodiments, an optical resonator is an arrangement of mirrors that forms a standing wave cavity resonator for light waves, e.g., a pair of mirrors on opposite ends of the gain medium and facing each other. The pair of mirrors includes a high reflector 217 and output coupler 205 surrounding the gain medium 201. Incident light 221 reflects between the mirrors creating standing wave 213. Some light is emitted as a laser beam 209. Where laser light is desired, the gain medium is positioned in an optical cavity. The optical cavity confines light in the gain medium, thereby feeding it amplified light back through the gain medium allowing it to be amplified again. Input light resonates between the mirrors while being re-amplified by the gain medium until the lasing threshold is surpassed and laser light is produced. This results in a positive feedback cycle tending to increase the gain G of the optical amplifier.


In a laser, one of the mirrors of the optical cavity is generally known as the high reflector while the other is the output coupler. Typically, the output coupler is partially transparent and emits the output laser beam. In certain embodiments, the invention provides a wavelength dependent reflector as a reflective surface with laser, such as one of the mirrors (e.g., the output coupler) or one of the facets of the gain medium.


A laser can be provided, for example, as a COTS component in a 14-pin butterfly package with either SMF or PMF pigtails. One such exemplary laser is the PowerPure 1998 PLM, a 980 nm pump laser module with Bragg grating available from Avanex Corporation (Fremont, Calif.).


In certain embodiments, a gain component such as an optical amplifier or a laser amplifies light in a frequency-specific manner. A gain component includes a gain medium having a gain coefficient g (gain per unit length) that is a function of the optical frequency of the incident signal w. The gain coefficient at a given frequency g(ω) is given by equation 3:

g(ω)=g0/(1+(ω−ω0)2T2+P/Ps)  (3)

where g0 is the peak gain of the medium, P is the optical power of the signal being amplified, Ps is the saturation power of the gain medium, ω0 is an atomic transition frequency of the medium, and T is a dipole relaxation time. Where incident light has a frequency ω, a gain medium has a gain coefficient g(ω) and gain is given by Equation 4:

G(ω)=exp[g(ω)L]  (4)

where L is a length of the gain medium.


The power of amplified light at a distance z from the input end of a gain medium is given by Equation 5:

P(z)=Pinexp(gz)  (5)


Gain coefficient g has an inverse square relationship to (ω−ω0) (see Equation 3) and power P(z) is exponentially related to gain coefficient g. Thus, the gain of a gain medium is higher for optical frequencies w closer to ω0. FIG. 8 shows gain as a function of wavelength for a typical gain medium. As shown by the peak of the gain curve, the gain medium has a “peak gain.”


If light of various wavelengths is amplified by the medium (at powers well below the saturation power Ps of the gain medium), light having a wavelength at or near the peak gain will be amplified to a greater degree than light having a wavelength not at or near the peak gain.


For any wavelength of light, if the gain is greater than the loss, lasing can result in which the light is emitted as a laser beam. The conditions at which gain equals loss is the lasing threshold for a frequency of light. The lasing threshold is lowest at the peak gain and light having a wavelength at the peak gain is more readily and more robustly amplified than at other wavelengths. Consequently, the gain medium most readily lases light at the peak gain.


Unintentional lasing is known as parasitic lasing. If light transmitted through the medium has sufficient power, wavelengths near the peak gain will cross the lasing threshold, causing lasing. This parasitic lasing leaches power from the system, reduces coherence length of signal light, and introduces noise into the signal. Due to the shape of the gain curve in a typical gain medium, parasitic lasing is problematic near the peak gain.


Devices and methods of the invention mitigate parasitic lasing and improve image quality. In one embodiment, systems and methods of the invention mitigate parasitic lasing by optimizing the time required to reach amplified light of a desired wavelength. Accordingly, undesired wavelengths have less opportunity to become amplified and also surpass the lasing threshold. In addition, image quality is also improved by reducing the time necessary to reach a desired wavelength.


In certain aspects, the gain component produces new infrared light from incident light delivered by a filter module in optical connection to the gain component. Preferably, the reflector is an output coupler and the gain component is a semiconductor optical amplifier. Systems of the invention further include any other compatible component known in the art. Exemplary components include interferometers, couplers/splitters, controllers, and any other device known in the art. Systems of the invention may include input and output mechanisms, such as an output mechanism configured to be coupled to a fiber optic interferometer or other imaging device. An optical system may include a controller component. For example, systems can include the LDC1300 butterfly LD/TEC controller from Thorlabs (Newton, N.J.). The LD/TEC controller and mount allows a system to be controlled by a computer. In certain embodiments, optical systems are integrated into an optical networking platform such as the Cisco ONS 15500 Dense Wave Division Multiplexer.


In certain embodiments, the system includes an interferometer such as a fiber optic interferometer. An interferometer, generally, is an instrument used to interfere waves and measure the interference. Interferometry includes extracting information from superimposed, interfering waves.


As encompassed by the invention, a portion of the amplified light leaving the gain chip assembly is directed back into the assembly. In certain aspects, this re-direction is accomplished using a partial mirror. Mirrors typically reflect uniformly over a broad spectral range. In contrast, partial mirrors work at off-normal angles of incidence, thereby reflecting only a portion of the light while transmitting the remainder. In certain aspects, a partial mirror is appropriately positioned outside the gain chip assembly so that when light leaves the assembly, it is reflected by the partial mirror back into the assembly. Accordingly, light is amplified a second time upon re-entering the gain chip assembly.


Any material suitable for antireflective coating may be used to construct the partial mirror. Exemplary materials include metals such as aluminum, silver, or gold or compounds such as magnesium fluoride. Additional exemplary coated materials are sold under the trademark HEBBAR by CVI Melles Griot (Albuquerque, N. Mex.).


Coatings of the desired thickness can be fabricated by any method known in the art including, for example, vacuum deposition, electric bombardment vaporization, plasma ion-assisted deposition (PIAD), carbon vapor deposition, plasma vapor deposition, and related techniques. In vacuum deposition, a substrate is put in a vacuum chamber along with a metal crucible holding the coating substance. A high current (e.g., 100 A) is passed through the coating material, vaporizing it. Due to the vacuum, the vaporized material disperses to the material to be coated.


In certain aspects, the filter and gain chip assembly are connected with optical fibers, such that light transmitted from the filter travels through the optical fiber to the gain chip assembly and from the gain chip assembly back into the filter. In certain aspects of the invention, one optical fiber transmits light from the filter to the gain chip assembly, while a second optical fiber transmits light from the gain chip assembly back to the filter.


Optical fibers are flexible, transparent fibers able to transmit light from one end of the fiber to the other. Optical fibers can be prepared from glass (silica) or from a variety of plastic polymers. Optical fibers usually include a transparent core surrounded by a transparent cladding material with a lower index of refraction. Light is kept in the core by total internal reflection, which causes the fiber to act as a waveguide or “light pipe.”


Any type of optical fiber is useful for practicing the invention, including multi-mode fibers (MMF) and single-mode fibers (SMF). MMF fibers support many propogation paths or transverse modes while SMF fibers support only a single mode. MMF fibers usually have wider core diameter than SMF fibers, and are used for short-distance communication links and for applications where high power must be transmitted. SMF fibers are often used for communication links longer than 1000 meters. Assemblies of multiple fibers can also be prepared in wrapped bundles, which are often used for imaging procedures. The selection of the appropriate fibers and their connection to the various components described herein is within the skill of the art. For example, MMF fibers having a wavelength range of 400-2400 nm are available from Thorlabs (Item No. AFS50/125Y).


Further embodiments of the invention include an optical circulator for redirecting light among the various components encompassed by the invention. For example, light can travel from the filter to the circulator through an optical fiber connecting both the filter and the circulator. The light can then travel from the circulator to the gain chip assembly and back again via a separate optical fiber connecting the circulator to the gain chip assembly.


An optical circulator is a special fiber-optic component that can be used to separate optical signals that travel in different directions in an optical fiber. Optical circulators are typically three-port devices, configured such that light entering any port exits from the next. This means that if light enters port 1, it is emitted from port 2, but if some of the emitted light is reflected back to the circulator, it does not come out of port 1, but instead exits from port 3. In this sense, fiber optic circulators act as signal routers, transmitting light from an input fiber at a first port to an output fiber at a second port, but directing light that returns along the output fiber to a third port. Circulators protect the input fiber from return power, but also allow the rejected light to be employed. The selection of the appropriate circulators and their connection to the various components described herein is within the skill of the art. For example, optical circulators having a wavelength range of 1525-1610 nm are available from Thorlabs, Inc (Item No. 6015-3-APC).


As encompassed by the invention, light from the filter enters the circulator at a first port, and exits the circulator at a second port, which is connected to the gain chip assembly. When the light amplified in the gain chip assembly reaches the lasing threshold, light is emitted from the gain chip assembly. The emitted light meets a partial mirror outside the gain chip assembly, whereupon a portion of the amplified light is reflected back into the assembly. The amplified light is amplified for a second time in the gain chip assembly. This re-amplified light travels back to the circulator, entering the circulator at the second port. The re-amplified light then exits the circulator out the third port, whereupon the re-amplified light travels back to the filter and the whole process can begin again.


The present invention can operate as a light source for a variety of uses, including imaging applications. In certain aspects, the unreflected portion of the light leaving the gain chip assembly is directed to an optical tomography (OCT) system. Systems and methods of the invention are particularly amenable for use in OCT as the provided systems and methods can improve image quality and reduce the incidence of parasitic lasing.


Measuring a phase change in one of two beams from a coherent light is employed in optical coherence tomography. Commercially available OCT systems are employed in diverse applications, including art conservation and diagnostic medicine, e.g., ophthalmology. Recently, it has also begun to be used in interventional cardiology to help diagnose coronary heart disease. OCT systems and methods are described in U.S. Patent Application Nos. 2011/0152771; 2010/0220334; 2009/0043191; 2008/0291463; and 2008/0180683, the contents of which are hereby incorporated by reference in their entirety.


Various lumen of biological structures may be imaged with the aforementioned imaging technologies in addition to blood vessels, including, but not limited to, vasculature of the lymphatic and nervous systems, various structures of the gastrointestinal tract including lumen of the small intestine, large intestine, stomach, esophagus, colon, pancreatic duct, bile duct, hepatic duct, lumen of the reproductive tract including the vas deferens, vagina, uterus, and fallopian tubes, structures of the urinary tract including urinary collecting ducts, renal tubules, ureter, bladder, and structures of the head, neck, and pulmonary system including sinuses, parotid, trachea, bronchi, and lungs.


In OCT, a light source delivers a beam of light to an imaging device to image target tissue. Within the light source is an optical amplifier and an tunable filter that allows that allows a user to select a wavelength of light to be amplified. Wavelengths commonly used in medical applications include near-infrared light, for example, 800 nm for shallow, high-resolution scans or 1700 nm for deep scans.


Generally, there are two types of OCT systems, common beam path systems and differential beam path systems, which differ from each other based upon the optical layout of the systems. A common beam path system sends all produced light through a single optical fiber to generate a reference signal and a sample signal, whereupon a differential beam path system splits the produced light such that a portion of the light is directed to the sample and the other portion is directed to a reference surface. The reflected light from the sample is recombined with the signal from the reference surface of detection. Common beam path interferometers are further described in, for example, U.S. Pat. Nos. 7,999,938; 7,995,210; and 7,787,127, the contents of which are incorporated by reference herein in its entirety.


In a differential beam path system, amplified light from a light source is inputted into an interferometer with a portion of light directed to a sample and the other portion directed to a reference surface. A distal end of an optical fiber is interfaced with a catheter for interrogation of the target tissue during a catheterization procedure. The reflected light from the tissue is recombined with the signal from the reference surface, forming interference fringes that allow precise depth-resolved imaging of the target tissue on a micron scale. Exemplary differential beam path interferometers are further described in, for example, U.S. Pat. Nos. 6,134,003; and 6,421,164, the contents of which are incorporated by reference herein in its entirety.


In certain embodiments, the invention can be used in conjunction with a differential beam path OCT system with intravascular imaging capability as illustrated in FIG. 4. In these embodiments, systems and methods of the invention can be used to provide a light source of narrow wavelength light. For intravascular imaging, a light beam is delivered to the vessel lumen via a fiber-optic based imaging catheter 826. The imaging catheter is connected through hardware to software on a host workstation. The hardware includes an imaging engine 859 and a handheld patient interface module (PIM) 839 that includes user controls. The proximal end of the imaging catheter is connected to PIM 839, which is connected to an imaging engine as shown in FIG. 4.


As shown in FIG. 5, the imaging engine 859 (e.g., bedside unit) houses a power supply 849, a light source 827 in accordance with the methods and systems described herein, interferometer 931, and variable delay line 835 as well as a data acquisition (DAQ) board 855 and optical controller board (OCB) 854. A PIM cable 841 connects the imaging engine 859 to the PIM 839 and an engine cable 845 connects the imaging engine 859 to the host workstation.



FIG. 6 shows the light path in an exemplary embodiment of the invention. Light for image capture originates within the light source 827. This light is split between an OCT interferometer 905 and an auxiliary interferometer 911. The OCT interferometer generates the OCT image signal and the auxiliary, or “clock” interferometer characterizes the wavelength tuning nonlinearity in the light source and generates a digitizer sample clock.


In certain embodiments, each interferometer is configured in a Mach-Zehnder layout and uses single mode fiber optics to guide the light. Fibers are connected via LC/APC connectors or protected fusion splices. By controlling the split ratio between the OCT and auxiliary interferometers with splitter 901, the optical power in the auxiliary interferometer is controlled to optimize the signal in the auxiliary interferometer. Within the auxiliary interferometer, light is split and recombined by a pair of 50/50 coupler/splitters.


Light directed to the main OCT interferometer is also split by splitter 917 and recombined by splitter 919 with an asymmetric split ratio. The majority of the light is guided into the sample path 913 and the remainder into a reference path 915. The sample path includes optical fibers running through the PIM 839 and the imaging catheter 826 and terminating at the distal end of the imaging catheter 826 where the image is captured.


Typical intravascular OCT involves introducing the imaging catheter into a patients' target vessel using standard interventional techniques and tools such as a guidewire, guide catheter, and angiography system. When operation is triggered from the PIM or control console, the imaging core of the catheter rotates while collecting image data that it delivers to the console screen. Rotation is driven by spin motor 861 while translation is driven by pullback motor 865, as shown in FIG. 7. Blood in the vessel is temporarily flushed with a clear solution while a motor translates the catheter longitudinally through the vessel.


In certain embodiments, the imaging catheter has a crossing profile of 2.4 F (0.8 mm) and transmits focused OCT imaging light to and from the vessel of interest. Embedded microprocessors running firmware in both the PIM and the imaging engine control the system. The imaging catheter includes a rotating and longitudinally-translating inner core contained within an outer sheath. Using light provided by the imaging engine, the inner core detects reflected light. This reflected light is then transmitted along a sample path to be recombined with the light from the reference path.


A variable delay line (VDL) 925 on the reference path uses an adjustable fiber coil to match the length of the reference path 915 to the length of the sample path 913. The reference path length is adjusted by translating a mirror on a lead screw based translation stage that is actuated electromechanically by a small stepper motor. The free-space optical beam on the inside of the VDL 925 experiences more delay as the mirror moves away from the fixed input/output fiber. Stepper movement is under firmware/software control.


Light from the reference path is combined with light from the sample path. This light is split into orthogonal polarization states, resulting in RF-band polarization-diverse temporal interference fringe signals. The interference fringe signals are converted to photocurrents using PIM photodiodes 929a and 929b on the OCG as shown in FIG. 6. The interfering, polarization splitting, and detection steps are performed by a polarization diversity module (PDM) on the OCB. Signal from the OCB is sent to the DAQ 855, shown in FIG. 5. The DAQ includes a digital signal processing (DSP) microprocessor and a field programmable gate array (FPGA) to digitize signals and communicate with the host work station and the PIM. The FPGA converts raw optical signals into meaningful OCT images. The DAQ also compresses data as necessary to reduce image transfer bandwidth to 1 Gbps.


In certain embodiments, the invention provides a light source for OCT including a filter, a gain chip assembly comprising a gain medium, and a partially reflecting mirror. The components are configured such that light passes from the filter to the gain chip assembly and a portion of the light is reflected by the partial mirror back through the gain chip assembly before the light passes again through the filter.


Any filter known in the art compatible with the invention may be used, including, for example, a tunable filter. The filter is included to deliver light of a specified wavelength into an optical amplifier. The filter typically has a peak reflectivity and a background reflectivity. In some embodiments, the system includes a commercial off-the-shelf (COTS) filter. One exemplary filter for use with the use with the invention is filter module TFM-687 by Axsun technologies, Inc. (Billerica, Mass.). An exemplary tunable optical filter exhibits 20% reflectivity and 29 dB contrast ratio.


Any optical amplifier or laser known in the art and compatible with the invention may be used as the gain component including, for example, a semiconductor optical amplifier. The amplifier amplifies the light to a sufficient output power for imaging by OCT. The amplifier typically has a semiconductor gain medium and an optical cavity. In some embodiments, a system includes a COTS amplifier. One exemplary optical amplifier for use with the invention is booster optical amplifier serial number BOA1130S, BOA1130P, or BOA-8702-11820.4.B01 from Thorlabs (Newton, N.J.). An exemplary optical amplifier has a center wavelength of 1285 nm and a small signal gain of 30 dB with a chip length of 1.5 mm.


A mirror can be coated with wavelength dependent material. Suitable materials are available from Unioriental Optics co., Ltd (Zhong Guan Cun Science Park, Beijing, China).


In certain embodiments, the invention provides a light source that emits narrow wavelength light for OCT systems like those shown in FIGS. 4 and 5. Exemplary components of light source 827 are illustrated schematically in FIG. 3. Tunable optical filter 801 provides light to an optical circulator 802 at a first port 802a via a first optical fiber 803. The light exits the circulator 802 at a second port 802b and travels through a second optical fiber 804 to a gain chip assembly 805. The operation of the gain chip assembly 805 has already been presented schematically in FIG. 2. When the light amplified in the gain chip assembly 805 reaches the lasing threshold, light is emitted from the assembly 805. The emitted light meets a partial mirror 806 outside the gain chip assembly 805, whereupon a portion of the light is reflected back into the assembly 805. The amplified light is amplified for a second time in the gain chip assembly 805. This re-amplified light travels back to the circulator 802 through the second optical fiber 804, entering the circulator 802 at the second port 802b. The re-amplified light then exits the circulator 802 out the third port 802c, whereupon the re-amplified light travels back to the filter 801 via a third optical fiber 807 and the whole process can begin again. Accordingly, systems and methods are able to produce narrow emissions of light faster than conventional methods by transmitting light through a filter and passing a portion of the filtered light through the gain chip assembly at least two times before that portion of filtered light passes again through the filter. This reduction in time to achieve the desired wavelength results in improved image quality and reduces the incidence of parasitic lasing.


INCORPORATION BY REFERENCE

References and citations to other documents, such as patents, patent applications, patent publications, journals, books, papers, web contents, have been made throughout this disclosure. All such documents are hereby incorporated herein by reference in their entirety for all purposes.


EQUIVALENTS

The invention may be embodied in other specific forms without departing from the spirit or essential characteristics thereof. The foregoing embodiments are therefore to be considered in all respects illustrative rather than limiting on the invention described herein. Scope of the invention is thus indicated by the appended claims rather than by the foregoing description, and all changes which come within the meaning and range of equivalency of the claims are therefore intended to be embraced therein.

Claims
  • 1. A method of narrowing a wavelength emission of light, the method comprising: transmitting light through a filter in a first direction;sending the light from the filter through an optical circulator to a gain medium in a gain chip assembly a first time;reflecting a portion of the light leaving the gain chip assembly back through the gain medium in the gain chip assembly a second time and back into the optical circulator;sending the reflected portion of the light from the gain chip assembly back through the filter again in the first direction;sending the reflected, filtered portion of the light through the optical circulator to the gain medium in the gain chip assembly for a third time;directing an unreflected portion of the light leaving the gain chip assembly, after the first time and after the third time, to an optical coherence tomography (OCT) system with intravascular imaging capability, such that the OCT system receives light that has passed twice through the filter and three times through the gain chip assembly.
  • 2. The method of claim 1, wherein reflecting is accomplished using a partial mirror.
  • 3. The method according to claim 1, wherein the filter is a tunable filter.
  • 4. The method of claim 3, wherein the filter is a voltage-controlled optical attenuator.
  • 5. The method of claim 1, wherein the gain medium is a semiconductor.
  • 6. A system for narrowing a wavelength emission of light, the system comprising: a filter;an optical circulator;a gain chip assembly comprising a gain medium,a partially reflecting mirror; the system being configured such that light passes from the filter in a first direction, through the optical circulator, to the gain chip assembly and a portion of the light is reflected by the partial mirror back through the gain chip assembly and back through the optical circulator where the light is directed through the filter again in the first direction, through the optical circulator, and back through the gain chip assembly and to the partial mirror again such that light reflected by the partial mirror is filtered once and passes through the gain chip assembly twice each time before reaching the partial mirror again;an optical coherence tomography (OCT) system with intravascular imaging capability wherein the OCT system is configured to receive an unreflected portion of the light that passes through the gain chip assembly.
  • 7. The system according to claim 6, wherein the filter is a tunable filter.
  • 8. The system of claim 7, wherein the filter is a voltage-controlled optical attenuator.
  • 9. The system of claim 8, wherein the gain medium is a semiconductor.
RELATED APPLICATION

This application claims the benefit of and priority to U.S. Provisional Application Ser. No. 61/745,270, filed Dec. 21, 2012, which is incorporated by reference in its entirety.

US Referenced Citations (1008)
Number Name Date Kind
3301258 Werner Jan 1967 A
3617880 Cormack et al. Nov 1971 A
3789841 Antoshkiw Feb 1974 A
3841308 Tate Oct 1974 A
4140364 Yamashita et al. Feb 1979 A
4274423 Mizuno et al. Jun 1981 A
4344438 Schultz Aug 1982 A
4398791 Dorsey Aug 1983 A
4432370 Hughes et al. Feb 1984 A
4552554 Gould et al. Nov 1985 A
4577543 Wilson Mar 1986 A
4676980 Segal et al. Jun 1987 A
4682895 Costello Jul 1987 A
4733665 Palmaz Mar 1988 A
4744619 Cameron May 1988 A
4762129 Bonzel Aug 1988 A
4766386 Oliver et al. Aug 1988 A
4771774 Simpson et al. Sep 1988 A
4794931 Yock Jan 1989 A
4800886 Nestor Jan 1989 A
4803639 Steele et al. Feb 1989 A
4816567 Cabilly et al. Mar 1989 A
4819740 Warrington Apr 1989 A
4821731 Martinelli et al. Apr 1989 A
4824435 Giesy et al. Apr 1989 A
4830023 de Toledo et al. May 1989 A
4834093 Littleford et al. May 1989 A
4841977 Griffith et al. Jun 1989 A
4864578 Proffitt et al. Sep 1989 A
4873690 Adams Oct 1989 A
4877314 Kanamori Oct 1989 A
4887606 Yock et al. Dec 1989 A
4917085 Smith Apr 1990 A
4917097 Proudian et al. Apr 1990 A
4928693 Goodin et al. May 1990 A
4932413 Shockey et al. Jun 1990 A
4932419 de Toledo Jun 1990 A
4948229 Soref Aug 1990 A
4951677 Crowley et al. Aug 1990 A
4969742 Falk et al. Nov 1990 A
4987412 Vaitekunas et al. Jan 1991 A
4993412 Murphy-Chutorian Feb 1991 A
4998972 Chin et al. Mar 1991 A
5000185 Yock Mar 1991 A
5024234 Leary et al. Jun 1991 A
5025445 Anderson et al. Jun 1991 A
5032123 Katz et al. Jul 1991 A
5037169 Chun Aug 1991 A
5039193 Snow et al. Aug 1991 A
5040548 Yock Aug 1991 A
5041108 Fox et al. Aug 1991 A
5054492 Scribner et al. Oct 1991 A
5065010 Knute Nov 1991 A
5065769 de Toledo Nov 1991 A
5085221 Ingebrigtsen et al. Feb 1992 A
5095911 Pomeranz Mar 1992 A
5100424 Jang et al. Mar 1992 A
5120308 Hess Jun 1992 A
5125137 Corl et al. Jun 1992 A
5135486 Eberle et al. Aug 1992 A
5135516 Sahatjian et al. Aug 1992 A
5155439 Holmbo et al. Oct 1992 A
5158548 Lau et al. Oct 1992 A
5163445 Christian et al. Nov 1992 A
5167233 Eberle et al. Dec 1992 A
5174295 Christian et al. Dec 1992 A
5176141 Bom et al. Jan 1993 A
5176674 Hofmann Jan 1993 A
5178159 Christian Jan 1993 A
5183048 Eberle Feb 1993 A
5188632 Goldenberg Feb 1993 A
5201316 Pomeranz et al. Apr 1993 A
5202745 Sorin et al. Apr 1993 A
5203779 Muller et al. Apr 1993 A
5220922 Barany Jun 1993 A
5224953 Morgentaler Jul 1993 A
5226421 Frisbie et al. Jul 1993 A
5240003 Lancee et al. Aug 1993 A
5240437 Christian Aug 1993 A
5242460 Klein et al. Sep 1993 A
5243988 Sieben et al. Sep 1993 A
5257974 Cox Nov 1993 A
5266302 Peyman et al. Nov 1993 A
5267954 Nita Dec 1993 A
5301001 Murphy et al. Apr 1994 A
5312425 Evans et al. May 1994 A
5313949 Yock May 1994 A
5313957 Little May 1994 A
5319492 Dorn et al. Jun 1994 A
5321501 Swanson et al. Jun 1994 A
5325198 Hartley et al. Jun 1994 A
5336178 Kaplan et al. Aug 1994 A
5346689 Peyman et al. Sep 1994 A
5348017 Thornton et al. Sep 1994 A
5348481 Ortiz Sep 1994 A
5353798 Sieben Oct 1994 A
5358409 Obara Oct 1994 A
5358478 Thompson et al. Oct 1994 A
5368037 Eberle et al. Nov 1994 A
5373845 Gardineer et al. Dec 1994 A
5373849 Maroney et al. Dec 1994 A
5375602 Lancee et al. Dec 1994 A
5377682 Ueno et al. Jan 1995 A
5383853 Jung et al. Jan 1995 A
5387193 Miraki Feb 1995 A
5396328 Jestel et al. Mar 1995 A
5397355 Marin et al. Mar 1995 A
5405377 Cragg Apr 1995 A
5411016 Kume et al. May 1995 A
5419777 Hofling May 1995 A
5421338 Crowley et al. Jun 1995 A
5423806 Dale et al. Jun 1995 A
5427118 Nita et al. Jun 1995 A
5431673 Summers et al. Jul 1995 A
5436759 Dijaili et al. Jul 1995 A
5439139 Brovelli Aug 1995 A
5443457 Ginn et al. Aug 1995 A
5453575 O'Donnell et al. Sep 1995 A
5456693 Conston et al. Oct 1995 A
5459570 Swanson et al. Oct 1995 A
5480388 Zadini et al. Jan 1996 A
5485845 Verdonk et al. Jan 1996 A
5492125 Kim et al. Feb 1996 A
5496997 Pope Mar 1996 A
5507761 Duer Apr 1996 A
5512044 Duer Apr 1996 A
5514128 Hillsman et al. May 1996 A
5529674 Hedgcoth Jun 1996 A
5541730 Chaney Jul 1996 A
5546717 Penczak et al. Aug 1996 A
5546948 Hamm et al. Aug 1996 A
5565332 Hoogenboom et al. Oct 1996 A
5573520 Schwartz et al. Nov 1996 A
5581638 Givens et al. Dec 1996 A
5586054 Jensen et al. Dec 1996 A
5592939 Martinelli Jan 1997 A
5596079 Smith et al. Jan 1997 A
5598844 Diaz et al. Feb 1997 A
5609606 O'Boyle Mar 1997 A
5630806 Inagaki et al. May 1997 A
5651366 Liang et al. Jul 1997 A
5660180 Malinowski et al. Aug 1997 A
5667499 Welch et al. Sep 1997 A
5667521 Keown Sep 1997 A
5672877 Liebig et al. Sep 1997 A
5674232 Halliburton Oct 1997 A
5693015 Walker et al. Dec 1997 A
5713848 Dubrul et al. Feb 1998 A
5745634 Garrett et al. Apr 1998 A
5771895 Slager Jun 1998 A
5779731 Leavitt Jul 1998 A
5780958 Strugach et al. Jul 1998 A
5798521 Froggatt Aug 1998 A
5800450 Lary et al. Sep 1998 A
5803083 Buck et al. Sep 1998 A
5814061 Osborne et al. Sep 1998 A
5817025 Alekseev et al. Oct 1998 A
5820594 Fontirroche et al. Oct 1998 A
5824520 Mulligan-Kehoe Oct 1998 A
5827313 Ream Oct 1998 A
5830222 Makower Nov 1998 A
5848121 Gupta et al. Dec 1998 A
5851464 Davila et al. Dec 1998 A
5857974 Eberle et al. Jan 1999 A
5872829 Wischmann et al. Feb 1999 A
5873835 Hastings et al. Feb 1999 A
5882722 Kydd Mar 1999 A
5912764 Togino Jun 1999 A
5916194 Jacobsen et al. Jun 1999 A
5921931 O'Donnell et al. Jul 1999 A
5925055 Adrian et al. Jul 1999 A
5949929 Hamm Sep 1999 A
5951586 Berg et al. Sep 1999 A
5974521 Akerib Oct 1999 A
5976120 Chow et al. Nov 1999 A
5978391 Das et al. Nov 1999 A
5997523 Jang Dec 1999 A
6021240 Murphy et al. Feb 2000 A
6022319 Willard et al. Feb 2000 A
6031071 Mandeville et al. Feb 2000 A
6036889 Kydd Mar 2000 A
6043883 Leckel et al. Mar 2000 A
6050949 White et al. Apr 2000 A
6059738 Stoltze et al. May 2000 A
6068638 Makower May 2000 A
6074362 Jang et al. Jun 2000 A
6078831 Belef et al. Jun 2000 A
6080109 Baker et al. Jun 2000 A
6091496 Hill Jul 2000 A
6094591 Foltz et al. Jul 2000 A
6095976 Nachtomy et al. Aug 2000 A
6097755 Guenther, Jr. et al. Aug 2000 A
6099471 Torp et al. Aug 2000 A
6099549 Bosma et al. Aug 2000 A
6102938 Evans et al. Aug 2000 A
6106476 Corl et al. Aug 2000 A
6120445 Grunwald Sep 2000 A
6123673 Eberle et al. Sep 2000 A
6134003 Tearney et al. Oct 2000 A
6139510 Palermo Oct 2000 A
6141089 Thoma et al. Oct 2000 A
6146328 Chiao et al. Nov 2000 A
6148095 Prause et al. Nov 2000 A
6151433 Dower et al. Nov 2000 A
6152877 Masters Nov 2000 A
6152878 Nachtomy et al. Nov 2000 A
6159225 Makower Dec 2000 A
6165127 Crowley Dec 2000 A
6176842 Tachibana et al. Jan 2001 B1
6179809 Khairkhahan et al. Jan 2001 B1
6186949 Hatfield et al. Feb 2001 B1
6190353 Makower et al. Feb 2001 B1
6200266 Shokrollahi et al. Mar 2001 B1
6200268 Vince et al. Mar 2001 B1
6203537 Adrian Mar 2001 B1
6208415 De Boer et al. Mar 2001 B1
6210332 Chiao et al. Apr 2001 B1
6210339 Kiepen et al. Apr 2001 B1
6212308 Donald Apr 2001 B1
6231518 Grabek et al. May 2001 B1
6245066 Morgan et al. Jun 2001 B1
6249076 Madden et al. Jun 2001 B1
6254543 Grunwald et al. Jul 2001 B1
6256090 Chen et al. Jul 2001 B1
6258052 Milo Jul 2001 B1
6261246 Pantages et al. Jul 2001 B1
6275628 Jones et al. Aug 2001 B1
6283921 Nix et al. Sep 2001 B1
6283951 Flaherty et al. Sep 2001 B1
6295308 Zah Sep 2001 B1
6299622 Snow et al. Oct 2001 B1
6312384 Chiao Nov 2001 B1
6325797 Stewart et al. Dec 2001 B1
6328696 Fraser Dec 2001 B1
6343168 Murphy et al. Jan 2002 B1
6343178 Burns et al. Jan 2002 B1
6350240 Song et al. Feb 2002 B1
6364841 White et al. Apr 2002 B1
6366722 Murphy et al. Apr 2002 B1
6367984 Stephenson et al. Apr 2002 B1
6373970 Dong et al. Apr 2002 B1
6375615 Flaherty et al. Apr 2002 B1
6375618 Chiao et al. Apr 2002 B1
6375628 Zadno-Azizi et al. Apr 2002 B1
6376830 Froggatt et al. Apr 2002 B1
6379352 Reynolds et al. Apr 2002 B1
6381350 Klingensmith et al. Apr 2002 B1
6387124 Buscemi et al. May 2002 B1
6396976 Little et al. May 2002 B1
6398792 O'Connor Jun 2002 B1
6417948 Chowdhury et al. Jul 2002 B1
6419644 White et al. Jul 2002 B1
6421164 Tearney et al. Jul 2002 B2
6423012 Kato et al. Jul 2002 B1
6426796 Pulliam et al. Jul 2002 B1
6428041 Wohllebe et al. Aug 2002 B1
6428498 Uflacker Aug 2002 B2
6429421 Meller et al. Aug 2002 B1
6440077 Jung et al. Aug 2002 B1
6443903 White et al. Sep 2002 B1
6450964 Webler Sep 2002 B1
6457365 Stephens et al. Oct 2002 B1
6459844 Pan Oct 2002 B1
6468290 Weldon et al. Oct 2002 B1
6475149 Sumanaweera Nov 2002 B1
6480285 Hill Nov 2002 B1
6491631 Chiao et al. Dec 2002 B2
6491636 Chenal et al. Dec 2002 B2
6501551 Tearney et al. Dec 2002 B1
6504286 Porat et al. Jan 2003 B1
6508824 Flaherty et al. Jan 2003 B1
6514237 Maseda Feb 2003 B1
6520269 Geiger et al. Feb 2003 B2
6520677 Iizuka Feb 2003 B2
6535764 Imran et al. Mar 2003 B2
6538778 Leckel et al. Mar 2003 B1
6544217 Gulachenski Apr 2003 B1
6544230 Flaherty et al. Apr 2003 B1
6545760 Froggatt et al. Apr 2003 B1
6546272 MacKinnon et al. Apr 2003 B1
6551250 Khalil Apr 2003 B2
6566648 Froggatt May 2003 B1
6570894 Anderson May 2003 B2
6572555 White et al. Jun 2003 B2
6577789 Wang Jun 2003 B1
6579311 Makower Jun 2003 B1
6584335 Haar et al. Jun 2003 B1
6592612 Samson et al. Jul 2003 B1
6594448 Herman et al. Jul 2003 B2
6602241 Makower et al. Aug 2003 B2
6611322 Nakayama et al. Aug 2003 B1
6611720 Hata et al. Aug 2003 B2
6612992 Hossack et al. Sep 2003 B1
6615062 Ryan et al. Sep 2003 B2
6615072 Izatt et al. Sep 2003 B1
6621562 Durston Sep 2003 B2
6631284 Nutt et al. Oct 2003 B2
6638227 Bae Oct 2003 B2
6645152 Jung et al. Nov 2003 B1
6646745 Verma et al. Nov 2003 B2
6655386 Makower et al. Dec 2003 B1
6659957 Vardi et al. Dec 2003 B1
6660024 Flaherty et al. Dec 2003 B1
6663565 Kawagishi et al. Dec 2003 B2
6665456 Dave et al. Dec 2003 B2
6669716 Gilson et al. Dec 2003 B1
6671055 Wavering et al. Dec 2003 B1
6673015 Glover et al. Jan 2004 B1
6673064 Rentrop Jan 2004 B1
6678087 Masuda et al. Jan 2004 B1
6685648 Flaherty et al. Feb 2004 B2
6689056 Kilcoyne et al. Feb 2004 B1
6689144 Gerberding Feb 2004 B2
6696173 Naundorf et al. Feb 2004 B1
6701044 Arbore et al. Mar 2004 B2
6701176 Halperin et al. Mar 2004 B1
6709444 Makower Mar 2004 B1
6712836 Berg et al. Mar 2004 B1
6714703 Lee et al. Mar 2004 B2
6719717 Johnson et al. Apr 2004 B1
6725073 Motamedi et al. Apr 2004 B1
6726677 Flaherty et al. Apr 2004 B1
6730107 Kelley et al. May 2004 B2
6733474 Kusleika May 2004 B2
6738144 Dogariu May 2004 B1
6740113 Vrba May 2004 B2
6746464 Makower Jun 2004 B1
6780157 Stephens et al. Aug 2004 B2
6795188 Ruck et al. Sep 2004 B2
6795196 Funakawa Sep 2004 B2
6798522 Stolte et al. Sep 2004 B2
6822798 Wu et al. Nov 2004 B2
6830559 Schock Dec 2004 B2
6832024 Gerstenberger et al. Dec 2004 B2
6842639 Winston et al. Jan 2005 B1
6847449 Bashkansky et al. Jan 2005 B2
6855115 Fonseca et al. Feb 2005 B2
6856138 Bohley Feb 2005 B2
6856400 Froggatt Feb 2005 B1
6856472 Herman et al. Feb 2005 B2
6860867 Seward et al. Mar 2005 B2
6866670 Rabiner et al. Mar 2005 B2
6878113 Miwa et al. Apr 2005 B2
6886411 Kjellman et al. May 2005 B2
6891984 Petersen et al. May 2005 B2
6895106 Wang et al. May 2005 B2
6898337 Averett et al. May 2005 B2
6900897 Froggatt May 2005 B2
6912051 Jensen Jun 2005 B2
6916329 Zhao Jul 2005 B1
6922498 Shah Jul 2005 B2
6937346 Nebendahl et al. Aug 2005 B2
6937696 Mostafavi Aug 2005 B1
6943939 DiJaili et al. Sep 2005 B1
6947147 Motamedi et al. Sep 2005 B2
6947787 Webler Sep 2005 B2
6949094 Yaron Sep 2005 B2
6952603 Gerber et al. Oct 2005 B2
6954737 Kalantar et al. Oct 2005 B2
6958042 Honda Oct 2005 B2
6961123 Wang et al. Nov 2005 B1
6966891 Ookubo et al. Nov 2005 B2
6969293 Thai Nov 2005 B2
6969395 Eskuri Nov 2005 B2
6985234 Anderson Jan 2006 B2
7004963 Wang et al. Feb 2006 B2
7006231 Ostrovsky et al. Feb 2006 B2
7010458 Wilt Mar 2006 B2
7024025 Sathyanarayana Apr 2006 B2
7027211 Ruffa Apr 2006 B1
7027743 Tucker et al. Apr 2006 B1
7033347 Appling Apr 2006 B2
7035484 Silberberg et al. Apr 2006 B2
7037269 Nix et al. May 2006 B2
7042573 Froggatt May 2006 B2
7044915 White et al. May 2006 B2
7044964 Jang et al. May 2006 B2
7048711 Rosenman et al. May 2006 B2
7049306 Konradi et al. May 2006 B2
7058239 Singh et al. Jun 2006 B2
7060033 White et al. Jun 2006 B2
7060421 Naundorf et al. Jun 2006 B2
7063679 Maguire et al. Jun 2006 B2
7068852 Braica Jun 2006 B2
7074188 Nair et al. Jul 2006 B2
7095493 Harres Aug 2006 B2
7110119 Maestle Sep 2006 B2
7113875 Terashima et al. Sep 2006 B2
7123777 Rondinelli et al. Oct 2006 B2
7130054 Ostrovsky et al. Oct 2006 B2
7139440 Rondinelli et al. Nov 2006 B2
7153299 Tu et al. Dec 2006 B1
7171078 Sasaki et al. Jan 2007 B2
7175597 Vince et al. Feb 2007 B2
7177491 Dave et al. Feb 2007 B2
7190464 Alphonse Mar 2007 B2
7215802 Klingensmith et al. May 2007 B2
7218811 Shigenaga et al. May 2007 B2
7236812 Ballerstadt et al. Jun 2007 B1
7245125 Harer et al. Jul 2007 B2
7245789 Bates et al. Jul 2007 B2
7249357 Landman et al. Jul 2007 B2
7291146 Steinke et al. Nov 2007 B2
7292715 Furnish Nov 2007 B2
7292885 Scott et al. Nov 2007 B2
7294124 Eidenschink Nov 2007 B2
7300460 Levine et al. Nov 2007 B2
7335161 Von Arx et al. Feb 2008 B2
7337079 Park et al. Feb 2008 B2
7355716 de Boer et al. Apr 2008 B2
7356367 Liang et al. Apr 2008 B2
7358921 Snyder et al. Apr 2008 B2
7359062 Chen et al. Apr 2008 B2
7359554 Klingensmith et al. Apr 2008 B2
7363927 Ravikumar Apr 2008 B2
7366376 Shishkov et al. Apr 2008 B2
7382949 Bouma et al. Jun 2008 B2
7387636 Cohn et al. Jun 2008 B2
7391520 Zhou et al. Jun 2008 B2
7397935 Kimmel et al. Jul 2008 B2
7399095 Rondinelli Jul 2008 B2
7408648 Kleen et al. Aug 2008 B2
7414779 Huber et al. Aug 2008 B2
7440087 Froggatt et al. Oct 2008 B2
7447388 Bates et al. Nov 2008 B2
7449821 Dausch Nov 2008 B2
7450165 Ahiska Nov 2008 B2
RE40608 Glover et al. Dec 2008 E
7458967 Appling et al. Dec 2008 B2
7463362 Lasker et al. Dec 2008 B2
7463759 Klingensmith et al. Dec 2008 B2
7491226 Palmaz et al. Feb 2009 B2
7515276 Froggatt et al. Apr 2009 B2
7527594 Vardi et al. May 2009 B2
7534251 WasDyke May 2009 B2
7535797 Peng et al. May 2009 B2
7547304 Johnson Jun 2009 B2
7564949 Sattler et al. Jul 2009 B2
7577471 Camus et al. Aug 2009 B2
7583857 Xu et al. Sep 2009 B2
7603165 Townsend et al. Oct 2009 B2
7612773 Magnin et al. Nov 2009 B2
7633627 Choma et al. Dec 2009 B2
7645229 Armstrong Jan 2010 B2
7658715 Park et al. Feb 2010 B2
7660452 Zwirn et al. Feb 2010 B2
7660492 Bates et al. Feb 2010 B2
7666204 Thornton et al. Feb 2010 B2
7672790 McGraw et al. Mar 2010 B2
7680247 Atzinger et al. Mar 2010 B2
7684991 Stohr et al. Mar 2010 B2
7711413 Feldman et al. May 2010 B2
7720322 Prisco May 2010 B2
7728986 Lasker et al. Jun 2010 B2
7734009 Brunner et al. Jun 2010 B2
7736317 Stephens et al. Jun 2010 B2
7742795 Stone et al. Jun 2010 B2
7743189 Brown et al. Jun 2010 B2
7762954 Nix et al. Jul 2010 B2
7766896 Kornkven Volk et al. Aug 2010 B2
7773792 Kimmel et al. Aug 2010 B2
7775981 Guracar et al. Aug 2010 B1
7777399 Eidenschink et al. Aug 2010 B2
7781724 Childers et al. Aug 2010 B2
7783337 Feldman et al. Aug 2010 B2
7787127 Galle et al. Aug 2010 B2
7792342 Barbu et al. Sep 2010 B2
7801343 Unal et al. Sep 2010 B2
7801590 Feldman et al. Sep 2010 B2
7813609 Petersen et al. Oct 2010 B2
7831081 Li Nov 2010 B2
7846101 Eberle et al. Dec 2010 B2
7853104 Oota et al. Dec 2010 B2
7853316 Milner et al. Dec 2010 B2
7860555 Saadat Dec 2010 B2
7862508 Davies et al. Jan 2011 B2
7872759 Tearney et al. Jan 2011 B2
7880868 Aoki Feb 2011 B2
7881763 Brauker et al. Feb 2011 B2
7909844 Alkhatib et al. Mar 2011 B2
7921854 Hennings et al. Apr 2011 B2
7927784 Simpson Apr 2011 B2
7929148 Kemp Apr 2011 B2
7930014 Huennekens et al. Apr 2011 B2
7930104 Baker et al. Apr 2011 B2
7936462 Jiang et al. May 2011 B2
7942852 Mas et al. May 2011 B2
7947012 Spurchise et al. May 2011 B2
7951186 Eidenschink et al. May 2011 B2
7952719 Brennan, III May 2011 B2
7972353 Hendriksen et al. Jul 2011 B2
7976492 Brauker et al. Jul 2011 B2
7977950 Maslen Jul 2011 B2
7978916 Klingensmith et al. Jul 2011 B2
7981041 McGahan Jul 2011 B2
7981151 Rowe Jul 2011 B2
7983737 Feldman et al. Jul 2011 B2
7993333 Oral et al. Aug 2011 B2
7995210 Tearney et al. Aug 2011 B2
7996060 Trofimov et al. Aug 2011 B2
7999938 Wang Aug 2011 B2
8021377 Eskuri Sep 2011 B2
8021420 Dolan Sep 2011 B2
8036732 Milner Oct 2011 B2
8040586 Smith et al. Oct 2011 B2
8047996 Goodnow et al. Nov 2011 B2
8049900 Kemp et al. Nov 2011 B2
8050478 Li et al. Nov 2011 B2
8050523 Younge et al. Nov 2011 B2
8052605 Muller et al. Nov 2011 B2
8057394 Dala-Krishna Nov 2011 B2
8059923 Bates et al. Nov 2011 B2
8070800 Lock et al. Dec 2011 B2
8080800 Hoctor et al. Dec 2011 B2
8088102 Adams et al. Jan 2012 B2
8100838 Wright et al. Jan 2012 B2
8104479 Glynn et al. Jan 2012 B2
8108030 Castella et al. Jan 2012 B2
8114102 Galdonik et al. Feb 2012 B2
8116605 Petersen et al. Feb 2012 B2
8125648 Milner et al. Feb 2012 B2
8126239 Sun et al. Feb 2012 B2
8133199 Weber et al. Mar 2012 B2
8133269 Flechsenhar et al. Mar 2012 B2
8140708 Zaharia et al. Mar 2012 B2
8148877 Jiang et al. Apr 2012 B2
8167932 Bourang et al. May 2012 B2
8172757 Jaffe et al. May 2012 B2
8177809 Mavani et al. May 2012 B2
8187191 Hancock et al. May 2012 B2
8187267 Pappone et al. May 2012 B2
8187830 Hu et al. May 2012 B2
8199218 Lee et al. Jun 2012 B2
8206429 Gregorich et al. Jun 2012 B2
8208995 Tearney et al. Jun 2012 B2
8222906 Wyar et al. Jul 2012 B2
8233681 Aylward et al. Jul 2012 B2
8233718 Klingensmith et al. Jul 2012 B2
8238624 Doi et al. Aug 2012 B2
8239938 Simeral et al. Aug 2012 B2
8277386 Ahmed et al. Oct 2012 B2
8280470 Milner et al. Oct 2012 B2
8289284 Glynn et al. Oct 2012 B2
8289522 Tearney et al. Oct 2012 B2
8298147 Huennekens et al. Oct 2012 B2
8298149 Hastings et al. Oct 2012 B2
8301000 Sillard et al. Oct 2012 B2
8309428 Lemmerhirt et al. Nov 2012 B2
8317713 Davies et al. Nov 2012 B2
8323201 Towfiq et al. Dec 2012 B2
8329053 Martin et al. Dec 2012 B2
8336643 Harleman Dec 2012 B2
8349000 Schreck Jan 2013 B2
8353945 Andreas et al. Jan 2013 B2
8353954 Cai et al. Jan 2013 B2
8357981 Martin et al. Jan 2013 B2
8361097 Patel et al. Jan 2013 B2
8386560 Ma et al. Feb 2013 B2
8398591 Mas et al. Mar 2013 B2
8412312 Judell et al. Apr 2013 B2
8417491 Trovato et al. Apr 2013 B2
8449465 Nair et al. May 2013 B2
8454685 Hariton et al. Jun 2013 B2
8454686 Alkhatib Jun 2013 B2
8475522 Jimenez et al. Jul 2013 B2
8478384 Schmitt et al. Jul 2013 B2
8486062 Belhe et al. Jul 2013 B2
8486063 Werneth et al. Jul 2013 B2
8491567 Magnin et al. Jul 2013 B2
8500798 Rowe et al. Aug 2013 B2
8550911 Sylla Oct 2013 B2
8594757 Boppart et al. Nov 2013 B2
8597349 Alkhatib Dec 2013 B2
8600477 Beyar et al. Dec 2013 B2
8600917 Schimert et al. Dec 2013 B1
8601056 Lauwers et al. Dec 2013 B2
8620055 Barratt et al. Dec 2013 B2
8644910 Rousso et al. Feb 2014 B2
20010007940 Tu et al. Jul 2001 A1
20010029337 Pantages et al. Oct 2001 A1
20010037073 White et al. Nov 2001 A1
20010046345 Snyder et al. Nov 2001 A1
20010049548 Vardi et al. Dec 2001 A1
20020034276 Hu et al. Mar 2002 A1
20020041723 Ronnekleiv et al. Apr 2002 A1
20020069676 Kopp et al. Jun 2002 A1
20020089335 Williams Jul 2002 A1
20020099289 Crowley Jul 2002 A1
20020163646 Anderson Nov 2002 A1
20020186818 Arnaud et al. Dec 2002 A1
20020196446 Roth et al. Dec 2002 A1
20020197456 Pope Dec 2002 A1
20030004412 Izatt et al. Jan 2003 A1
20030016604 Hanes Jan 2003 A1
20030018273 Corl et al. Jan 2003 A1
20030023153 Izatt et al. Jan 2003 A1
20030032886 Dgany et al. Feb 2003 A1
20030050871 Broughton Mar 2003 A1
20030065371 Satake Apr 2003 A1
20030069723 Hegde Apr 2003 A1
20030077043 Hamm et al. Apr 2003 A1
20030085635 Davidsen May 2003 A1
20030090753 Takeyama et al. May 2003 A1
20030092995 Thompson May 2003 A1
20030093059 Griffin et al. May 2003 A1
20030103212 Westphal et al. Jun 2003 A1
20030152259 Belykh et al. Aug 2003 A1
20030181802 Ogawa Sep 2003 A1
20030187369 Lewis et al. Oct 2003 A1
20030194165 Silberberg et al. Oct 2003 A1
20030195419 Harada Oct 2003 A1
20030208116 Liang et al. Nov 2003 A1
20030212491 Mitchell et al. Nov 2003 A1
20030219202 Loeb et al. Nov 2003 A1
20030220749 Chen et al. Nov 2003 A1
20030228039 Green Dec 2003 A1
20040015065 Panescu et al. Jan 2004 A1
20040023317 Motamedi et al. Feb 2004 A1
20040028333 Lomas Feb 2004 A1
20040037742 Jen et al. Feb 2004 A1
20040042066 Kinoshita et al. Mar 2004 A1
20040054287 Stephens Mar 2004 A1
20040067000 Bates et al. Apr 2004 A1
20040068161 Couvillon Apr 2004 A1
20040082844 Vardi et al. Apr 2004 A1
20040092830 Scott et al. May 2004 A1
20040106853 Moriyama Jun 2004 A1
20040111552 Arimilli et al. Jun 2004 A1
20040126048 Dave et al. Jul 2004 A1
20040143160 Couvillon Jul 2004 A1
20040146546 Gravett et al. Jul 2004 A1
20040186369 Lam Sep 2004 A1
20040186558 Pavcnik et al. Sep 2004 A1
20040195512 Crosetto Oct 2004 A1
20040220606 Goshgarian Nov 2004 A1
20040225220 Rich Nov 2004 A1
20040239938 Izatt Dec 2004 A1
20040242990 Brister et al. Dec 2004 A1
20040248439 Gernhardt et al. Dec 2004 A1
20040260236 Manning et al. Dec 2004 A1
20050013778 Green et al. Jan 2005 A1
20050031176 Hertel et al. Feb 2005 A1
20050036150 Izatt et al. Feb 2005 A1
20050078317 Law et al. Apr 2005 A1
20050101859 Maschke May 2005 A1
20050140582 Lee et al. Jun 2005 A1
20050140682 Sumanaweera et al. Jun 2005 A1
20050140981 Waelti Jun 2005 A1
20050140984 Hitzenberger Jun 2005 A1
20050147303 Zhou et al. Jul 2005 A1
20050165439 Weber et al. Jul 2005 A1
20050171433 Boppart et al. Aug 2005 A1
20050171438 Chen et al. Aug 2005 A1
20050182297 Gravenstein et al. Aug 2005 A1
20050196028 Kleen et al. Sep 2005 A1
20050197585 Brockway et al. Sep 2005 A1
20050213103 Everett et al. Sep 2005 A1
20050215942 Abrahamson et al. Sep 2005 A1
20050234445 Conquergood et al. Oct 2005 A1
20050243322 Lasker et al. Nov 2005 A1
20050249391 Kimmel et al. Nov 2005 A1
20050251567 Ballew et al. Nov 2005 A1
20050254059 Alphonse Nov 2005 A1
20050264823 Zhu et al. Dec 2005 A1
20060013523 Childlers et al. Jan 2006 A1
20060015126 Sher Jan 2006 A1
20060024066 Fujiwara et al. Feb 2006 A1
20060029634 Berg et al. Feb 2006 A1
20060036167 Shina Feb 2006 A1
20060038115 Maas Feb 2006 A1
20060039004 de Boer et al. Feb 2006 A1
20060041180 Viswanathan et al. Feb 2006 A1
20060045536 Arahira Mar 2006 A1
20060055936 Yun et al. Mar 2006 A1
20060058622 Tearney et al. Mar 2006 A1
20060064009 Webler et al. Mar 2006 A1
20060067620 Shishkov et al. Mar 2006 A1
20060072808 Grimm et al. Apr 2006 A1
20060074442 Noriega et al. Apr 2006 A1
20060098927 Schmidt et al. May 2006 A1
20060100694 Globerman May 2006 A1
20060106375 Werneth et al. May 2006 A1
20060132790 Gutin Jun 2006 A1
20060135870 Webler Jun 2006 A1
20060142703 Carter et al. Jun 2006 A1
20060142733 Forsberg Jun 2006 A1
20060173299 Romley et al. Aug 2006 A1
20060179255 Yamazaki Aug 2006 A1
20060184048 Saadat Aug 2006 A1
20060187537 Huber et al. Aug 2006 A1
20060195269 Yeatman et al. Aug 2006 A1
20060204119 Feng et al. Sep 2006 A1
20060229591 Lee Oct 2006 A1
20060239312 Kewitsch et al. Oct 2006 A1
20060241342 Macaulay et al. Oct 2006 A1
20060241465 Huennekens et al. Oct 2006 A1
20060241492 Boese Oct 2006 A1
20060241503 Schmitt et al. Oct 2006 A1
20060244973 Yun et al. Nov 2006 A1
20060258895 Maschke Nov 2006 A1
20060264743 Kleen et al. Nov 2006 A1
20060267756 Kates Nov 2006 A1
20060270976 Savage et al. Nov 2006 A1
20060276709 Khamene et al. Dec 2006 A1
20060279742 Tearney et al. Dec 2006 A1
20060279743 Boesser et al. Dec 2006 A1
20060285638 Boese et al. Dec 2006 A1
20060287595 Maschke Dec 2006 A1
20060293597 Johnson et al. Dec 2006 A1
20070015969 Feldman et al. Jan 2007 A1
20070016029 Donaldson et al. Jan 2007 A1
20070016034 Donaldson Jan 2007 A1
20070016062 Park et al. Jan 2007 A1
20070027390 Maschke et al. Feb 2007 A1
20070036417 Argiro et al. Feb 2007 A1
20070038061 Huennekens et al. Feb 2007 A1
20070038121 Feldman et al. Feb 2007 A1
20070038125 Kleen et al. Feb 2007 A1
20070043292 Camus et al. Feb 2007 A1
20070043597 Donaldson Feb 2007 A1
20070049847 Osborne Mar 2007 A1
20070060973 Ludvig et al. Mar 2007 A1
20070065077 Childers et al. Mar 2007 A1
20070066888 Maschke Mar 2007 A1
20070066890 Maschke Mar 2007 A1
20070066983 Maschke Mar 2007 A1
20070084995 Newton et al. Apr 2007 A1
20070100226 Yankelevitz et al. May 2007 A1
20070135887 Maschke Jun 2007 A1
20070142707 Wiklof et al. Jun 2007 A1
20070156019 Larkin et al. Jul 2007 A1
20070161893 Milner et al. Jul 2007 A1
20070161896 Adachi et al. Jul 2007 A1
20070161963 Smalling Jul 2007 A1
20070162860 Muralidharan et al. Jul 2007 A1
20070165141 Srinivas et al. Jul 2007 A1
20070167710 Unal et al. Jul 2007 A1
20070167804 Park et al. Jul 2007 A1
20070191682 Rolland et al. Aug 2007 A1
20070201127 Maeda Aug 2007 A1
20070201736 Klingensmith et al. Aug 2007 A1
20070206193 Pesach Sep 2007 A1
20070208276 Kornkven Volk et al. Sep 2007 A1
20070225220 Ming et al. Sep 2007 A1
20070225590 Ramos Sep 2007 A1
20070229801 Tearney et al. Oct 2007 A1
20070232872 Prough et al. Oct 2007 A1
20070232874 Ince Oct 2007 A1
20070232890 Hirota Oct 2007 A1
20070232891 Hirota Oct 2007 A1
20070232892 Hirota Oct 2007 A1
20070232893 Tanioka Oct 2007 A1
20070232933 Gille et al. Oct 2007 A1
20070238957 Yared Oct 2007 A1
20070247033 Eidenschink et al. Oct 2007 A1
20070250000 Magnin et al. Oct 2007 A1
20070250036 Volk et al. Oct 2007 A1
20070258094 Izatt et al. Nov 2007 A1
20070260138 Feldman et al. Nov 2007 A1
20070278389 Ajgaonkar et al. Dec 2007 A1
20070287914 Cohen Dec 2007 A1
20080002183 Yatagai et al. Jan 2008 A1
20080013093 Izatt et al. Jan 2008 A1
20080021275 Tearney et al. Jan 2008 A1
20080027481 Gilson et al. Jan 2008 A1
20080043024 Schiwietz et al. Feb 2008 A1
20080045842 Furnish Feb 2008 A1
20080051660 Kakadaris et al. Feb 2008 A1
20080063304 Russak et al. Mar 2008 A1
20080085041 Breeuwer Apr 2008 A1
20080095465 Mullick et al. Apr 2008 A1
20080095714 Castella et al. Apr 2008 A1
20080097194 Milner Apr 2008 A1
20080101667 Begelman et al. May 2008 A1
20080108867 Zhou May 2008 A1
20080114254 Matcovitch et al. May 2008 A1
20080119739 Vardi et al. May 2008 A1
20080124495 Horn et al. May 2008 A1
20080125772 Stone et al. May 2008 A1
20080139897 Ainsworth et al. Jun 2008 A1
20080143707 Mitchell Jun 2008 A1
20080146941 Dala-Krishna Jun 2008 A1
20080147111 Johnson et al. Jun 2008 A1
20080154128 Milner Jun 2008 A1
20080161696 Schmitt et al. Jul 2008 A1
20080171944 Brenneman et al. Jul 2008 A1
20080175465 Jiang et al. Jul 2008 A1
20080177183 Courtney et al. Jul 2008 A1
20080180683 Kemp Jul 2008 A1
20080181477 Izatt et al. Jul 2008 A1
20080187201 Liang et al. Aug 2008 A1
20080228086 Ilegbusi et al. Sep 2008 A1
20080247622 Aylward et al. Oct 2008 A1
20080247716 Thomas et al. Oct 2008 A1
20080262470 Lee et al. Oct 2008 A1
20080262489 Steinke Oct 2008 A1
20080269599 Csavoy et al. Oct 2008 A1
20080281205 Naghavi et al. Nov 2008 A1
20080281248 Angheloiu et al. Nov 2008 A1
20080285043 Fercher et al. Nov 2008 A1
20080287795 Klingensmith et al. Nov 2008 A1
20080291463 Milner et al. Nov 2008 A1
20080292173 Hsieh et al. Nov 2008 A1
20080294034 Krueger et al. Nov 2008 A1
20080298655 Edwards Dec 2008 A1
20080306766 Ozeki et al. Dec 2008 A1
20090009801 Tabuki Jan 2009 A1
20090018393 Dick et al. Jan 2009 A1
20090021724 Mahadevan-Jansen Jan 2009 A1
20090034813 Dikmen et al. Feb 2009 A1
20090043191 Castella et al. Feb 2009 A1
20090046295 Kemp et al. Feb 2009 A1
20090052614 Hempel et al. Feb 2009 A1
20090069843 Agnew Mar 2009 A1
20090079993 Yatagai et al. Mar 2009 A1
20090088650 Corl Apr 2009 A1
20090093980 Kemp et al. Apr 2009 A1
20090122320 Petersen et al. May 2009 A1
20090138544 Wegenkittl et al. May 2009 A1
20090149739 Maschke Jun 2009 A9
20090156941 Moore Jun 2009 A1
20090174886 Inoue Jul 2009 A1
20090174931 Huber et al. Jul 2009 A1
20090177090 Grunwald et al. Jul 2009 A1
20090177183 Pinkernell et al. Jul 2009 A1
20090195514 Glynn et al. Aug 2009 A1
20090196470 Carl et al. Aug 2009 A1
20090198125 Nakabayashi et al. Aug 2009 A1
20090203991 Papaioannou et al. Aug 2009 A1
20090264768 Courtney et al. Oct 2009 A1
20090269014 Winberg et al. Oct 2009 A1
20090270695 McEowen Oct 2009 A1
20090284322 Harrison et al. Nov 2009 A1
20090284332 Moore et al. Nov 2009 A1
20090284749 Johnson et al. Nov 2009 A1
20090290167 Flanders et al. Nov 2009 A1
20090292048 Li et al. Nov 2009 A1
20090299195 Muller et al. Dec 2009 A1
20090299284 Holman et al. Dec 2009 A1
20090318951 Kashkarov et al. Dec 2009 A1
20090326634 Vardi Dec 2009 A1
20100007669 Bethune et al. Jan 2010 A1
20100030042 Denninghoff et al. Feb 2010 A1
20100061611 Xu et al. Mar 2010 A1
20100063400 Hall et al. Mar 2010 A1
20100087732 Eberle et al. Apr 2010 A1
20100094125 Younge et al. Apr 2010 A1
20100094127 Xu Apr 2010 A1
20100094135 Fang-Yen et al. Apr 2010 A1
20100094143 Mahapatra et al. Apr 2010 A1
20100097614 Kourogi et al. Apr 2010 A1
20100113919 Maschke May 2010 A1
20100125238 Lye et al. May 2010 A1
20100125268 Gustus et al. May 2010 A1
20100125648 Zaharia et al. May 2010 A1
20100128348 Taverner May 2010 A1
20100152717 Keeler Jun 2010 A1
20100160788 Davies et al. Jun 2010 A1
20100161023 Cohen et al. Jun 2010 A1
20100168714 Burke et al. Jul 2010 A1
20100179421 Tupin Jul 2010 A1
20100179426 Davies et al. Jul 2010 A1
20100220334 Condit et al. Sep 2010 A1
20100226607 Zhang et al. Sep 2010 A1
20100234736 Corl Sep 2010 A1
20100249601 Courtney Sep 2010 A1
20100256616 Katoh et al. Oct 2010 A1
20100272432 Johnson Oct 2010 A1
20100284590 Peng et al. Nov 2010 A1
20100290693 Cohen et al. Nov 2010 A1
20100331950 Strommer Dec 2010 A1
20110010925 Nix et al. Jan 2011 A1
20110021926 Spencer et al. Jan 2011 A1
20110025853 Richardson Feb 2011 A1
20110026797 Declerck et al. Feb 2011 A1
20110032533 Izatt et al. Feb 2011 A1
20110034801 Baumgart Feb 2011 A1
20110044546 Pan et al. Feb 2011 A1
20110051143 Flanders et al. Mar 2011 A1
20110066073 Kuiper et al. Mar 2011 A1
20110071401 Hastings et al. Mar 2011 A1
20110072405 Chen et al. Mar 2011 A1
20110077528 Kemp et al. Mar 2011 A1
20110080591 Johnson et al. Apr 2011 A1
20110087104 Moore et al. Apr 2011 A1
20110137140 Tearney et al. Jun 2011 A1
20110144502 Zhou et al. Jun 2011 A1
20110152771 Milner et al. Jun 2011 A1
20110157597 Lu et al. Jun 2011 A1
20110157686 Huber et al. Jun 2011 A1
20110160586 Li et al. Jun 2011 A1
20110178413 Schmitt et al. Jul 2011 A1
20110190586 Kemp Aug 2011 A1
20110216378 Poon et al. Sep 2011 A1
20110220985 Son et al. Sep 2011 A1
20110238061 van der Weide et al. Sep 2011 A1
20110238083 Moll et al. Sep 2011 A1
20110245669 Zhang Oct 2011 A1
20110249094 Wang et al. Oct 2011 A1
20110257545 Suri Oct 2011 A1
20110264125 Wilson et al. Oct 2011 A1
20110274329 Mathew et al. Nov 2011 A1
20110282334 Groenhoff Nov 2011 A1
20110301684 Fischell et al. Dec 2011 A1
20110306995 Moberg Dec 2011 A1
20110319752 Steinberg et al. Dec 2011 A1
20120004529 Tolkowsky et al. Jan 2012 A1
20120004668 Wallace et al. Jan 2012 A1
20120013914 Kemp et al. Jan 2012 A1
20120016344 Kusakabe Jan 2012 A1
20120016395 Olson Jan 2012 A1
20120022360 Kemp Jan 2012 A1
20120026503 Lewandowski et al. Feb 2012 A1
20120029007 Graham et al. Feb 2012 A1
20120059253 Wang et al. Mar 2012 A1
20120059368 Takaoka et al. Mar 2012 A1
20120062843 Ferguson et al. Mar 2012 A1
20120065481 Hunter et al. Mar 2012 A1
20120071823 Chen Mar 2012 A1
20120071838 Fojtik Mar 2012 A1
20120075638 Rollins et al. Mar 2012 A1
20120083696 Kitamura Apr 2012 A1
20120095340 Smith Apr 2012 A1
20120095372 Sverdlik et al. Apr 2012 A1
20120108943 Bates et al. May 2012 A1
20120113108 Dala-Krishna May 2012 A1
20120116353 Arnold et al. May 2012 A1
20120130243 Balocco et al. May 2012 A1
20120130247 Waters et al. May 2012 A1
20120136259 Milner et al. May 2012 A1
20120136427 Palmaz et al. May 2012 A1
20120137075 Vorbach May 2012 A1
20120155734 Barratt et al. Jun 2012 A1
20120158101 Stone et al. Jun 2012 A1
20120162660 Kemp Jun 2012 A1
20120165661 Kemp et al. Jun 2012 A1
20120170848 Kemp et al. Jul 2012 A1
20120172698 Teo et al. Jul 2012 A1
20120176607 Ott Jul 2012 A1
20120184853 Waters Jul 2012 A1
20120184859 Shah et al. Jul 2012 A1
20120184977 Wolf Jul 2012 A1
20120215094 Rahimian et al. Aug 2012 A1
20120220836 Alpert et al. Aug 2012 A1
20120220851 Razansky et al. Aug 2012 A1
20120220865 Brown et al. Aug 2012 A1
20120220874 Hancock et al. Aug 2012 A1
20120220883 Manstrom et al. Aug 2012 A1
20120224751 Kemp et al. Sep 2012 A1
20120226153 Brown et al. Sep 2012 A1
20120230565 Steinberg et al. Sep 2012 A1
20120232400 Dickinson et al. Sep 2012 A1
20120238869 Schmitt et al. Sep 2012 A1
20120238956 Yamada et al. Sep 2012 A1
20120244043 Leblanc et al. Sep 2012 A1
20120250028 Schmitt et al. Oct 2012 A1
20120253186 Simpson et al. Oct 2012 A1
20120253192 Cressman Oct 2012 A1
20120253276 Govari et al. Oct 2012 A1
20120257210 Whitney et al. Oct 2012 A1
20120262720 Brown et al. Oct 2012 A1
20120265077 Gille et al. Oct 2012 A1
20120265268 Blum et al. Oct 2012 A1
20120265296 McNamara et al. Oct 2012 A1
20120271170 Emelianov et al. Oct 2012 A1
20120271175 Moore et al. Oct 2012 A1
20120271339 O'Beirne et al. Oct 2012 A1
20120274338 Baks et al. Nov 2012 A1
20120276390 Ji et al. Nov 2012 A1
20120277722 Gerber et al. Nov 2012 A1
20120279764 Jiang et al. Nov 2012 A1
20120283758 Miller et al. Nov 2012 A1
20120289987 Wilson et al. Nov 2012 A1
20120299439 Huang Nov 2012 A1
20120310081 Adler et al. Dec 2012 A1
20120310332 Murray et al. Dec 2012 A1
20120319535 Dausch Dec 2012 A1
20120323075 Younge et al. Dec 2012 A1
20120323127 Boyden et al. Dec 2012 A1
20120330141 Brown et al. Dec 2012 A1
20130015975 Huennekens et al. Jan 2013 A1
20130023762 Huennekens et al. Jan 2013 A1
20130023763 Huennekens et al. Jan 2013 A1
20130026655 Lee et al. Jan 2013 A1
20130030295 Huennekens et al. Jan 2013 A1
20130030303 Ahmed et al. Jan 2013 A1
20130030410 Drasler et al. Jan 2013 A1
20130053949 Pintor et al. Feb 2013 A1
20130109958 Baumgart et al. May 2013 A1
20130109959 Baumgart et al. May 2013 A1
20130137980 Waters et al. May 2013 A1
20130150716 Stigall et al. Jun 2013 A1
20130158594 Carrison et al. Jun 2013 A1
20130218201 Obermiller et al. Aug 2013 A1
20130218267 Braido et al. Aug 2013 A1
20130223789 Lee et al. Aug 2013 A1
20130223798 Jenner et al. Aug 2013 A1
20130296704 Magnin et al. Nov 2013 A1
20130303907 Corl Nov 2013 A1
20130303920 Corl Nov 2013 A1
20130310698 Judell et al. Nov 2013 A1
20130331820 Itou et al. Dec 2013 A1
20130338766 Hastings et al. Dec 2013 A1
20130339958 Droste et al. Dec 2013 A1
20140039294 Jiang Feb 2014 A1
20140180067 Stigall et al. Jun 2014 A1
20140180128 Corl Jun 2014 A1
20140200438 Millett et al. Jul 2014 A1
Foreign Referenced Citations (79)
Number Date Country
1041373 Oct 2000 EP
01172637 Jan 2002 EP
2438877 Apr 2012 EP
2280261 Jan 1995 GB
2000-262461 Sep 2000 JP
2000-292260 Oct 2000 JP
2001-125009 May 2001 JP
2001-272331 Oct 2001 JP
2002-374034 Dec 2002 JP
2003-143783 May 2003 JP
2003-172690 Jun 2003 JP
2003-256876 Sep 2003 JP
2003-287534 Oct 2003 JP
2005-274380 Oct 2005 JP
2006-184284 Jul 2006 JP
2006-266797 Oct 2006 JP
2006-313158 Nov 2006 JP
2007-024677 Feb 2007 JP
2009-233001 Oct 2009 JP
2011-56786 Mar 2011 JP
9101156 Feb 1991 WO
9216865 Oct 1992 WO
9306213 Apr 1993 WO
9308829 May 1993 WO
9838907 Sep 1998 WO
9857583 Dec 1998 WO
0011511 Mar 2000 WO
0044296 Aug 2000 WO
0111409 Feb 2001 WO
03062802 Jul 2003 WO
03073950 Sep 2003 WO
2004010856 Feb 2004 WO
2004023992 Mar 2004 WO
2004096049 Nov 2004 WO
2005047813 May 2005 WO
2005106695 Nov 2005 WO
2006029634 Mar 2006 WO
2006037132 Apr 2006 WO
2006039091 Apr 2006 WO
2006061829 Jun 2006 WO
2006068875 Jun 2006 WO
2006111704 Oct 2006 WO
2006119416 Nov 2006 WO
2006121851 Nov 2006 WO
2006130802 Dec 2006 WO
2007002685 Jan 2007 WO
2007025230 Mar 2007 WO
2007045690 Apr 2007 WO
2007058895 May 2007 WO
2007067323 Jun 2007 WO
2007084995 Jul 2007 WO
2008058084 May 2008 WO
2008069991 Jun 2008 WO
2008107905 Sep 2008 WO
2009009799 Jan 2009 WO
2009009801 Jan 2009 WO
2009046431 Apr 2009 WO
2009121067 Oct 2009 WO
2009137704 Nov 2009 WO
201106886 Jan 2011 WO
2011038048 Mar 2011 WO
2011081688 Jul 2011 WO
2012003369 Jan 2012 WO
2012061935 May 2012 WO
2012071388 May 2012 WO
2012087818 Jun 2012 WO
2012098194 Jul 2012 WO
2012109676 Aug 2012 WO
2012130289 Oct 2012 WO
2012154767 Nov 2012 WO
2012155040 Nov 2012 WO
2013033414 Mar 2013 WO
2013033415 Mar 2013 WO
2013033418 Mar 2013 WO
2013033489 Mar 2013 WO
2013033490 Mar 2013 WO
2013033592 Mar 2013 WO
2013126390 Aug 2013 WO
2014109879 Jul 2014 WO
Non-Patent Literature Citations (191)
Entry
Sihan et al., 2008, A novel approach to quantitative analysis of intraluminal optical coherence tomography imaging, Comput. Cardiol:1089-1092.
Siwy et al., 2003, Electro-responsive asymmetric nanopores in polyimide with stable ion-current signal, Applied Physics A: Materials Science & Processing 76:781-785.
Smith et al., 1989, Absolute displacement measurements using modulation of the spectrum of white light in a Michelson interferometer, Applied Optics, 28(16):3339-3342.
Smith, 1997, The Scientist and Engineer's Guide to Digital Signal Processing, California Technical Publishing, San Diego, CA:432-436.
Soller, 2003, Polarization diverse optical frequency domain interferonnetry:All coupler implementation, Bragg Grating, Photosensitivity, and Poling in Glass Waveguides Conference MB4:30-32.
Song et al., 2012, Active tremor cancellation by a “Smart” handheld vitreoretinal microsurgical tool using swept source optical coherence tomography, Optics Express, 20(21):23414-23421.
Stenqvist et al., 1983, Stiffness of central venous catheters, Acta Anaesthesiol Scand., 2:153-157.
Strickland, 1970, Time-Domain Reflectometer Measurements, Tektronix, Beaverton, OR, (107 pages).
Strobl et al., 2009, An Introduction to Recursive Partitioning:Rationale, Application and Characteristics of Classification and Regression Trees, Bagging and Random Forests, Psychol Methods., 14(4):323-348.
Sutcliffe et al., 1986, Dynamics of UV laser ablation of organic polymer surfaces, Journal of Applied Physics, 60 (9):3315-3322.
Suzuki, 2013, A novel guidewire approach for handling acute-angle bifurcations, J Inv Cardiol 25(1):48-54.
Tanimoto et al., 2008, A novel approach for quantitative analysis of intracoronary optical coherence tomography: high inter-observer agreement with computer-assisted contour detection, Cathet Cardiovascular Intervent, 72(2):228-235.
Tearney et al., 1997, In vivo Endoscopic Optical Biopsy with Optical Coherence Tomography, Science, 276:2037-2039.
Tonino et al., 2009, Fractional flow reserve versus angiography for guiding percutaneous coronary intervention, The New England Journal of Medicine, 360:213-224.
Toregeani et al., 2008, Evaluation of hemodialysis arteriovenous fistula maturation by color-flow Doppler ultrasound, J Vasc. Bras. 7(3):203-213.
Translation of Notice of Reason(s) for Refusal dated Apr. 30, 2014, for Japanese Patent Application No. 2011-508677, (5 pages).
Translation of Notice of Reason(s) for Refusal dated May 25, 2012, for Japanese Patent Application No. 2009-536425, (3 pages).
Translation of Notice of Reason(s) for Refusal dated Nov. 22, 2012, for Japanese Patent Application No. 2010-516304, (6 pages).
Traunecker et al., 1991, Bispecific single chain molecules (Janusins) target cytotoxic lymphocytes on HIV infected cells, EMBO J., 10:3655-3659.
Trolier-McKinstry et. al., 2004, Thin Film Piezoelectric for MEMS, Journal of Electroceramics 12:7-17.
Tuniz et al., 2010, Weaving the invisible thread: design of an optically invisible metamaterial fibre, Optics Express 18(17):18095-18105.
Turk et al., 1991, Eigenfaces for Recognition, Journal of Cognitive Neuroscience 3(1):71-86.
Tuzel et al., 2006, Region Covariance: A Fast Descriptor for Detection and Classification, European Conference on Computer Vision (ECCV).
Urban et al., 2010, Design of a Pressure Sensor Based on Optical Bragg Grating Lateral Deformation, Sensors (Basel), 10(12):11212-11225.
Vakhtin et al., 2003, Common-path interferometer for frequency-domain optical coherence tomography, Applied Optics, 42(34):6953-6958.
Vakoc et al., 2005, Phase-Resolved Optical Frequency Domain Imaging, Optics Express 13(14):5483-5493.
Verhoeyen et al., 1988, Reshaping human antibodies: grafting an antilysozyme activity, Science, 239:1534-1536.
Villard et al., 2002, Use of a blood substitute to determine instantaneous murine right ventricular thickening with optical coherence tomography, Circulation, 105:1843-1849.
Wang et al., 2002, Optimizing the Beam Patten of a Forward-Viewing Ring-Annular Ultrasound Array for Intravascular Imaging, Transactions on Ultrasonics, Ferroelectrics, and Frequency Control, 49(12).
Wang et al., 2006, Multiple biomarkers for the prediction of first major cardiovascular events and death, The New England Journal of Medicine, 355(25):2631-2639.
Wang et al., 2009, Robust Guidewire Tracking in Fluoroscopy, IEEE Conference on Computer Vision and Pattern Recognition—CVPR 2009:691-698.
Wang et al., 2011, In vivo intracardiac optical coherence tomography imaging through percutaneous access: toward image-guided radio-frequency ablation, J. Biomed. Opt. 0001 16(11):110505-1 (3 pages).
Waterhouse et. al., 1993, Combinatorial infection and in vivo recombination: a strategy for making large phage antibody repertoires, Nucleic Acids Res., 21:2265-2266.
Wegener, 2011, 3D Photonic Metamaterials and Invisibility Cloaks: The Method of Making, MEMS 2011, Cancun, Mexico, Jan. 23-27, 2011.
West et al., 1991, Arterial insufficiency in hemodialysis access procedures: correction by banding technique, Transpl Proc 23(2):1838-40.
Wyawahare et al., 2009, Image registration techniques: an overview, International Journal of Signal Processing, Image Processing and Pattern Recognition, 2(3):11-28.
Yaqoob et al., 2006, Methods and application areas of endoscopic optical coherence tomography, J. Biomed. Opt., 11, 063001-1-063001-19.
Yasuno et al., 2004, Polarization-sensitive complex Fourier domain optical coherence tomography for Jones matrix imaging of biological samples, Applied Physics Letters 85(15):3023-3025.
Zhang et al., 2004, Full range polarization-sensitive Fourier domain optical coherence tomography, Optics Express, 12 (24):6033-6039.
Zitova et al., 2003, Image registration methods: A survey. Image and Vision Computing, 21(11):977-1000.
Little et al., 1991, The underlying coronary lesion in myocardial infarction:implications for coronary angiography, Clinical Cardiology, 14(11):868-874.
Loo, 2004, Nanoshell Enabled Photonics-Based Imaging and Therapy of Cancer, Technology in Cancer Research & Treatment 3(1):33-40.
Machine translation of JP 2000-097846.
Machine translation of JP 2000-321034.
Machine translation of JP 2000-329534.
Machine translation of JP 2004-004080.
Maintz et al., 1998, An Overview of Medical Image Registration Methods, Technical Report UU-CS, (22 pages).
Mamas et al., 2010, Resting Pd/Pa measured with intracoronary pressure wire strongly predicts fractional flow reserve, Journal of Invasive Cardiology 22(6):260-265.
Marks et al., 1991, By-passing Immunization Human Antibodies from V-gene Libraries Displayed on Phage, J. Mol. Biol. 222:581-597.
Marks et al., 1992, By-Passing Immunization:Building High Affinity Human Antibodies by Chain Shuffling, BioTechnol., 10:779-783.
Maruno et al., 1991, Fluorine containing optical adhesives for optical communications systems, J. Appl. Polymer. Sci. 42:2141-2148.
McCafferty et al., 1990, Phage antibodies: filamentous phage displaying antibody variable domains, Nature 348:552-554.
Mendieta et al., 1996, Complementary sequence correlations with applications to reflectometry studies, Instrumentation and Development 3(6):37-46.
Mickley, 2008, Steal Syndrome-strategies to preserve vascular access and extremity, Nephrol Dial Transplant 23:19-24.
Miller et al., 2010, The MILLER banding procedure is an effective method for treating dialysis-associated steal syndrome, Kidney International 77:359-366.
Milstein et al., 1983, Hybrid hybridomas and their use in immunohistochemistry, Nature 305:537-540.
Mindlin et al., 1936, A force at a point of a semi-infinite solid, Physics, 7:195-202.
Morrison et al., 1984, Chimeric human antibody molecules: mouse antigen-binding domains with human constant region domains, PNAS 81:6851-6855.
Munson et al., 1980, Ligand: a versatile computerized approach for characterization of ligand-binding systems, Analytical Biochemistry, 107:220-239.
Nezam, 2008, High Speed Polygon-Scanner-Based Wavelength-Swept Laser Source in the Telescope-Less Configurations with Application in Optical Coherence Tomography, Optics Letters 33(15):1741-1743.
Nissen, 2001, Coronary Angiography and Intravascular Ultrasound, American Journal of Cardiology, 87 (suppl):15A-20A.
Nitenberg et al., 1995, Coronary vascular reserve in humans: a critical review of methods of evaluation and of interpretation of the results, Eur Heart J. 16(Suppl 1):7-21.
Notice of Reason(s) for Refusal dated Apr. 30, 2013, for Japanese Patent Application No. 2011-508677 for Optical Imaging Catheter for Aberation Balancing to Volcano Corporation, which application is a Japanese national stage entry of PCT/US2009/043181 with international filed May 7, 2009, of the same title, published on Nov. 12, 2009, as WO 2009/137704, and accompanying English translation of the Notice of Reason(s) for Refusal and machine translations of JP11-56786 and JP2004-290548 (56 pages).
Nygren, 1982, Conjugation of horseradish peroxidase to Fab fragments with different homobifunctional and heterobifunctional cross-linking reagents. A comparative study, J. Histochem. and Cytochem. 30:407-412.
Oesterle et al., 1986, Angioplasty at coronary bifurcations: single-guide, two-wire technique, Cathet Cardiovasc Diagn., 12:57-63.
Okuno et al., 2003, Recent Advances in Optical Switches Using Silica-based PLC Technology, NTT Technical Review 1(7):20-30.
Oldenburg et al., 1998, Nanoengineering of Optical Resonances, Chemical Physics Letters 288:243-247.
Oldenburg et al., 2003, Fast-Fourier-Domain Delay Line for In Vivo Optical Coherence Tomography with a Polygonal Scanner, Applied Optics, 42(22):4606-4611.
Othonos, 1997, Fiber Bragg gratings, Review of Scientific Instruments 68(12):4309-4341.
Owens et al., 2007, A Survey of General-Purpose Computation on Graphics Hardware, Computer Graphics Forum 26 (1):80-113.
Pain et al., 1981, Preparation of protein A-peroxidase mono conjugate using a heterobifunctional reagent, and its use in enzyme immunoassays, J Immunol Methods, 40:219-30.
Park et al., 2005, Real-time fiber-based multi-functional spectral-domain optical coherence tomography at 1.3 um., Optics Express 13(11):3931-3944.
Pasquesi et al., 2006, In vivo detection of exercise induced ultrastructural changes in genetically-altered murine skeletal muscle using polarization-sensitive optical coherence tomography, Optics Express 14(4)1 547-1556.
Pepe et al., 2004, Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker, American Journal of Epidemiology 159(9):882-890.
Persson et al., 1985, Acoustic impedance matching of medical ultrasound transducers, Ultrasonics, 23(2):83-89.
Placht et al., 2012, Fast time-of-flight camera based surface registration for radiotherapy patient positioning, Medical Physics 39(1):4-17.
Rabbani et al., 1999, Review: Strategies to achieve coronary arterial plaque stabilization, Cardiovascular Research 41:402-417.
Radvany et al., 2008, Plaque Excision in Management of Lower Extremity Peripheral Arterial Disease with the SilverHawk Atherectomy Catheter, Seminars in Interventional Radiology, 25(1):11-19.
Reddy et al., 1996, An FFT-Based Technique for Translation, Rotation, and Scale-Invariant Image Registration, IEEE Transaction on Image Processing 5(8):1266-1271.
Riechmann et al., 1988, Reshaping human antibodies for therapy, Nature, 332:323-327.
Rivers et al., 1992, Correction of steal syndrome secondary to hemodialysis access fistulas: a simplified quantitative technique, Surgery, 112(3):593-7.
Robbin et al., 2002, Hemodialysis Arteriovenous Fistula Maturity: US Evaluation, Radiology 225:59-64.
Rollins et al., 1998, In vivo video rate optical coherence tomography, Optics Express 3:219-229.
Sarunic et al., 2005, Instantaneous Complex Conjugate Resolved Spectral Domain and Swept-Source OCT Using 3x3 Fiber Couplers, Optics Express 13(3):957-967.
Satiani et al., 2009, Predicted Shortage of Vascular Surgeons in the United States, J. Vascular Surgery 50:946-952.
Schneider et al., 2006, T-banding: A technique for flow reduction of a hyper-functioning arteriovenous fistula, J Vase Surg. 43(2):402-405.
Sen et al., 2012, Development and validation of a new adenosine-independent index of stenosis severity from coronary wave-intensity analysis, Journal of the American College of Cardiology 59(15):1392-1402.
Setta et al., 2005, Soft versus firm embryo transfer catheters for assisted reproduction: a systematic review and meta-analysis, Human Reproduction, 20(11):3114-3121.
Seward et al., 1996, Ultrasound Cardioscopy: Embarking on New Journey, Mayo Clinic Proceedings 71(7):629-635.
Shen et al., 2006, Eigengene-based linear discriminant model for tumor classification using gene expression microarray data, Bioinformatics 22(21):2635-2642.
Abdi et al., 2010, Principal component analysis, Wiley Interdisciplinary Reviews: Computational Statistics 2:433-459.
Adler et al., 2007, Phase-Sensitive Optical Coherence Tomography at up to 370,000 Lines Per Second Using Buffered Fourier Domain Mode-Locked Lasers, Optics Letters, 32(6):626-628.
Agresti, 1996, Models for Matched Pairs, Chapter 8, An Introduction to Categorical Data Analysis, Wiley-Interscience A John Wiley & Sons, Inc., Publication, Hoboken, New Jersey.
Akasheh et al., 2004, Development of piezoelectric micromachined ultrasonic transducers, Sensors and Actuators A Physical, 111:275-287.
Amini et al., 1990, Using dynamic programming for solving variational problems in vision, IEEE Transactions on Pattern Analysis and Machine Intelligence, 12(9):855-867.
Bail et al., 1996, Optical coherence tomography with the “Spectral Radar”—Fast optical analysis in volume scatterers by short coherence interferometry, Optics Letters 21(14):1087-1089.
Bain, 2011, Privacy protection and face recognition, Chapter 3, Handbook of Face Recognition, Stan et al., Springer-Verlag.
Barnea et al., 1972, A class of algorithms for fast digital image registration, IEEE Trans. Computers, 21(2):179-186.
Blanchet et al., 1993, Laser Ablation and the Production of Polymer Films, Science, 262(5134):719-721.
Bonnema, 2008, Imaging Tissue Engineered Blood Vessel Mimics with Optical Tomography, College of Optical Sciences dissertation, University of Arizona (252 pages).
Bouma et al., 1999, Power-efficient nonreciprocal interferometer and linear-scanning fiber-optic catheter for optical coherence tomography, Optics Letters, 24(8):531-533.
Breiman, 2001, Random forests, Machine Learning 45:5-32.
Brown, 1992, A survey of image registration techniques, ACM Computing Surveys 24(4):325-376.
Bruining et al., 2009, Intravascular Ultrasound Registration/Integration with Coronary Angiography, Cardiology Clinics, 27(3):531-540.
Brummer, 1997, An euclidean distance measure between covariance matrices of speechcepstra for text-independent speaker recognition, in Proc. South African Symp. Communications and Signal Processing:167-172.
Burr et al., 2005, Searching for the Center of an Ellipse in Proceedings of the 17th Canadian Conference on Computational Geometry:260-263.
Canny, 1986, A computational approach to edge detection, IEEE Trans. Pattern Anal. Mach. Intell. 8:679-698.
Cavalli et al., 2010, Nanosponge formulations as oxygen delivery systems, International Journal of Pharmaceutics 402:254-257.
Choma et al., 2003, Sensitivity Advantage of Swept Source and Fourier Domain Optical Coherence Tomography, Optics Express 11(18):2183-2189.
Clarke et al., 1995, Hypoxia and myocardial ischaemia during peripheral angioplasty, Clinical Radiology, 50(5):301-303.
Collins, 1993, Coronary flow reserve, British Heart Journal 69:279-281.
Communication Mechanisms for Distributed Real-Time Applications, NI Developer Zone, http://zone.ni.eom/devzone/cda/tut/p/id/3105, accessed Jul. 23, 2007.
Cook, 2007, Use and misuse of receiver operating characteristic curve in risk prediction, Circulation 115(7):928-35.
D'Agostino et al., 2001, Validation of the Framingham coronary heart disease prediction score: results of a multiple ethnic group investigation, JAMA 286:180-187.
David et al., 1974, Protein iodination with solid-state lactoperoxidase, Biochemistry 13:1014-1021.
Davies et al., 1985, Plaque fissuring-the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina, British Heart Journal 53:363-373.
Davies et al., 1993, Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content, British Heart Journal 69:377-381.
Deterministic Data Streaming in Distributed Data Acquisition Systems, NI Developer Zone, “What is Developer Zone?”, http://zone.ni.eom/devzone/cda/tut/p/id/3105, accessed Jul. 23, 2007.
Eigenwillig, 2008, K-Space Linear Fourier Domain Mode Locked Laser and Applications for Optical Coherence Tomography, Optics Express 16(12):8916-8937.
Elghanian et al., 1997, Selective colorimetric detection of polynucleotides based on the distance-dependent optical properties of gold nanoparticles, Science, 277(5329):1078-1080.
Ergun et al., 2003, Capacitive Micromachined Ultrasonic Transducers:Theory and Technology, Journal of Aerospace Engineering, 16(2):76-84.
Evans et al., 2006, Optical coherence tomography to identify intramucosa carcinoma and high-grade dysplasia in Barrett's esophagus, Clin Gast Hepat 4(1):38-43.
Fatemi et al., 1999, Vibro-acoustography: an imaging modality based on ultrasound-stimulated acoustic emission, PNAS U.S.A., 96(12):6603-6608.
Felzenszwalb et al., 2005, Pictorial Structures for Object Recognition, International Journal of Computer Vision, 61 (1):55-79.
Ferring et al., 2008, Vasculature ultrasound for the pre-operative evaluation prior to arteriovenous fistula formation for haemodialysis: review of the evidence, Nephrol. Dial. Transplant. 23(6):1809-1815.
Fischler et al., 1973, The representation and matching of pictorial structures, IEEE Transactions on Computer 22:67-92.
Fleming et al., 2010, Real-time monitoring of cardiac radio-frequency ablation lesion formation using an optical coherence tomography forward-imaging catheter, Journal of Biomedical Optics 15 (3):030516-1 (3 pages).
Fookes et al., 2002, Rigid and non-rigid image registration and its association with mutual information:A review, Technical Report ISBN:1 86435 569 7, RCCVA, QUT.
Forstner & Moonen, 1999, A metric for covariance matrices, In Technical Report of the Dpt of Geodesy and Geoinformatics, Stuttgart University, 113-128.
Goel et al., 2006, Minimally Invasive Limited Ligation Endoluminal-assisted Revision (MILLER) for treatment of dialysis access-associated steal syndrome, Kidney Int 70(4):765-70.
Gotzinger et al., 2005, High speed spectral domain polarization sensitive optical coherence tomography of the human retina, Optics Express 13(25):10217-10229.
Gould et al., 1974, Physiologic basis for assessing critical coronary stenosis, American Journal of Cardiology, 33:87-94.
Griffiths et al., 1993, Human anti-self antibodies with high specificity from phage display libraries, The EMBO Journal, 12:725-734.
Griffiths et al., 1994, Isolation of high affinity human antibodies directly from large synthetic repertoires, The EMBO Journal, 13(14):3245-3260.
Grund et al., 2010, Analysis of biomarker data:logs, odds, ratios and ROC curves, Curr Opin HIV AIDS 5(6):473-479.
Harrison et al., 2011, Guidewire Stiffness: What's in a name?, J Endovasc Ther, 18(6):797-801.
Huber et al., 2005, Amplified, Frequency Swept Lasers for Frequency Domain Reflectometry and OCT Imaging: Design and Scaling Principles, Optics Express 13(9):3513-3528.
Huber et al., 2006, Fourier Domain Mode Locking (FDML): A New Laser Operating Regime and Applications for Optical Coherence Tomography, Optics Express 14(8):3225-3237.
International Search Report and Written Opinion mailed Mar. 11, 2014, for International Patent Application No. PCT/US13/75675, filed Dec. 17, 2013 (7 pages).
International Search Report and Written Opinion mailed Mar. 19, 2014, for International Patent Application No. PCT/US13/075353, filed Dec. 16, 2013 (8 pages).
International Search Report and Written Opinion mailed Nov. 2, 2012, for International Patent Application No. PCT/US12/53168, filed Aug. 30, 2013 (8 pages).
International Search Report and Written Opinion mailed on Apr. 14, 2014, for International Patent Application No. PCT/US2013/076148, filed Dec. 18, 2013 (8 pages).
International Search Report and Written Opinion mailed on Apr. 21, 2014, for International Patent Application No. PCT/US2013/076015, filed Dec. 18, 2013 (7 pages).
International Search Report and Written Opinion mailed on Apr. 23, 2014, for International Patent Application No. PCT/US2013/075328, filed Dec. 16, 2013 (8 pages).
International Search Report and Written Opinion mailed on Apr. 29, 2014, for International Patent Application No. PCT/US13/76093, filed Dec. 18, 2013 (6 pages).
International Search Report and Written Opinion mailed on Apr. 9, 2014, for International Patent Application No. PCT/US13/75089, filed Dec. 13, 2013 (7 pages).
International Search Report and Written Opinion mailed on Feb. 21, 2014, for International Patent Application No. PCT/US13/76053, filed Dec. 18, 2013 (9 pages).
International Search Report and Written Opinion mailed on Feb. 21, 2014, for International Patent Application No. PCT/US2013/076965, filed Dec. 20, 2013 (6 pages).
International Search Report and Written Opinion mailed on Feb. 27, 2014, for International Patent Application No. PCT/US13/75416, filed Dec. 16, 2013 (7 pages).
International Search Report and Written Opinion mailed on Feb. 28, 2014, for International Patent Application No. PCT/US13/75653, filed Dec. 17, 2013 (7 pages).
International Search Report and Written Opinion mailed on Feb. 28, 2014, for International Patent Application No. PCT/US13/75990, filed Dec. 18, 2013 (7 pages).
International Search Report and Written Opinion mailed on Jan. 16, 2009, for International Patent Application No. PCT/US08/78963 filed on Oct. 6, 2008 (7 pages).
International Search Report and Written Opinion mailed on Jul. 30, 2014, for International Patent Application No. PCT/US14/21659, filed Mar. 7, 2014 (15 pages).
International Search Report and Written Opinion mailed on Mar. 10, 2014, for International Patent Application No. PCT/US2013/076212, filed Dec. 18, 2013 (8 pages).
International Search Report and Written Opinion mailed on Mar. 11, 2014, for International Patent Application No. PCT/US13/76173, filed Dec. 16, 2013 (9 pages).
International Search Report and Written Opinion mailed on Mar. 11, 2014, for International Patent Application No. PCT/US13/76449, filed Dec. 19, 2013 (9 pages).
International Search Report and Written Opinion mailed on Mar. 18, 2014, for International Patent Application No. PCT/US2013/076502, filed Dec. 19, 2013 (7 pages).
International Search Report and Written Opinion mailed on Mar. 18, 2014, for International Patent Application No. PCT/US2013/076788, filed Dec. 20, 2013 (7 pages).
International Search Report and Written Opinion mailed on Mar. 19, 2014, for International Patent Application No. PCT/US13/75349, filed Dec. 16, 2013 (10 pages).
International Search Report and Written Opinion mailed on Mar. 19, 2014, for International Patent Application No. PCT/US2013/076587, filed Dec. 19, 2013 (10 pages).
International Search Report and Written Opinion mailed on Mar. 19, 2014, for International Patent Application No. PCT/US2013/076909, filed Dec. 20, 2013 (7 pages).
International Search Report and Written Opinion mailed on Mar. 7, 2014, for International Patent Application No. PCT/US2013/076304, filed Dec. 18, 2013 (9 pages).
International Search Report and Written Opinion mailed on Mar. 7, 2014, for International Patent Application No. PCT/US2013/076480, filed Dec. 19, 2013 (8 pages).
International Search Report and Written Opinion mailed on Mar. 7, 2014, for International Patent Application No. PCT/US2013/076512, filed Dec. 19, 2013 (8 pages).
International Search Report and Written Opinion mailed on Mar. 7, 2014, for International Patent Application No. PCT/US2013/076531, filed Dec. 19, 2013 (10 pages).
Jakobovits et al., 1993, Analysis of homozygous mutant chimeric mice:deletion of the immunoglobulin heavy-chain joining region blocks B-cell development and antibody production, PNAS USA 90:2551-255.
Jakobovits et al., 1993, Germ-line transmission and expression of a human-derived yeast artificial chromosome, Nature 362:255-258.
Jang et al., 2002, Visualization of Coronary Atherosclerotic Plaques in Patients Using Optical Coherence Tomography: Comparison With Intravascular Ultrasound, Journal of the American College of Cardiology 39:604-609.
Jiang et al., 1992, Image registration of multimodality 3-D medical images by chamfer matching, Proc. SPIE 1660, Biomedical Image Processing and Three-Dimensional Microscopy, 356-366.
Johnson et al., 1993, Human antibody engineering: Current Opinion in Structural Biology, 3:564-571.
Jones et al., 1986, Replacing the complementarity-determining regions in a human antibody with those from a mouse, Nature, 321:522-525.
Juviler et al., 2008, Anorectal sepsis and fistula-in-ano, Surgical Technology International, 17:139-149.
Karapatis et al., 1998, Direct rapid tooling:a review of current research, Rapid Prototyping Journal, 4(2):77-89.
Karp et al., 2009, The benefit of time-of-flight in PET imaging, J Nucl Med 49:462-470.
Kelly et al., 2005, Detection of Vascular Adhesion Molecule-1 Expression Using a Novel Multimodal Nanoparticle, Circulation Research 96:327-336.
Kemp et al., 2005, Depth Resolved Optic Axis Orientation in Multiple Layered Anisotropic Tissues Measured with Enhanced Polarization Sensitive Optical Coherence Tomography, Optics Express 13(12):4507-4518.
Kersey et al., 1991, Polarization insensitive fiber optic Michelson interferometer, Electron. Lett. 27:518-520.
Kheir et al., 2012, Oxygen Gas-Filled Microparticles Provide Intravenous Oxygen Delivery, Science Translational Medicine 4(140):140ra88 (10 pages).
Khuri-Yakub et al., 2011, Capacitive micromachined ultrasonic transducers for medical imaging and therapy, J Micromech Microeng. 21(5):054004-054014.
Kirkman, 1991, Technique for flow reduction in dialysis access fistulas, Surg Gyn Obstet, 172(3):231-3.
Kohler et al., 1975, Continuous cultures of fused cells secreting antibody of predefined specificity, Nature, 256:495-7.
Koo et al., 2011, Diagnosis of IschemiaCausing Coronary Stenoses by Noninvasive Fractional Flow Reserve Computed From Coronary Computed Tomographic Angiograms, J Am Coll Cardiol 58(19):1989-1997.
Kozbor et al., 1984, A human hybrid myeloma for production of human monoclonal antibodies, J. Immunol., 133:3001-3005.
Kruth et al., 2003, Lasers and materials in selective laser sintering, Assembly Automation, 23(4):357-371.
Kumagai et al., 1994, Ablation of polymer films by a femtosecond high-peak-power Ti:sapphire laser at 798 nm, Applied Physics Letters, 65(14):1850-1852.
Larin et al., 2002, Noninvasive Blood Glucose Monitoring with Optical Coherence Tomography: a pilot study in human subjects, Diabetes Care, 25(12):2263-7.
Larin et al., 2004, Measurement of Refractive Index Variation of Physiological Analytes using Differential Phase OCT, Proc of SPIE 5325:31-34.
Laufer, 1996, Introduction to Optics and Lasers in Engineering, Cambridge University Press, Cambridge UK:156-162.
Lefevre et al., 2001, Stenting of bifurcation lesions:a rational approach, J. Interv. Cardiol., 14(6):573-585.
Li et al., 2000, Optical Coherence Tomography: Advanced Technology for the Endoscopic Imaging of Barrett's Esophagus, Endoscopy, 32(12):921-930.
International Search Report and Written Opinion mailed on Apr. 16, 2014, for International Patent Application No. PCT/US2013/075636, filed Dec. 17, 2013 (8 pages).
Related Publications (1)
Number Date Country
20140177237 A1 Jun 2014 US
Provisional Applications (1)
Number Date Country
61745270 Dec 2012 US